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Abstract 
 
 Secondary ion mass spectrometry (SIMS) returns chemically specific data on 
membrane component distribution and composition.  Of particular interest is a 
membrane protein’s lipid environment, which may play a role in the protein’s function.  
Herein, this thesis describes the synthesis of fluorine-functionalized colloidal gold 
immunolabels that facilitate the imaging of specific proteins in parallel with stable 
isotope labeled lipids in the cellular membrane using high-resolution SIMS performed 
with a NanoSIMS (Figure 1).  Further, the spatial statistical analysis tools are outlined 
and applied to NanoSIMS data to test the hypothesis of colocalization of the flu virus 
protein hemagglutinin and sphingolipids. 
 
Figure 1 Schematic of protein and lipid labeling for NanoSIMS detection. 
 While the NanoSIMS has very high lateral resolution, it requires isotope labels for 
component identification.  Time-of-flight SIMS (TOF-SIMS) detects large portions of the 
mass spectrum, allowing species to be identified by their fragmentation pattern.  
Ionization yields in TOF-SIMS, however, limit the lateral resolution and the maximum 
m/z that can be used consistently for analysis.  These challenges can be addressed 
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using multivariate analysis (MVA).  TOF-SIMS and the MVA method partial least 
squares discriminant analysis (PLS-DA) was used to identify the differentiation stage of 
hematopoietic cells.  Since TOF-SIMS is a location-specific technique, it can be used to 
investigate how varying chemical and material environments on one sample affect stem 
cell fate decisions.  Another MVA method, partial least squares regression (PLSR), uses 
a calibrated model to return quantitative information from TOF-SIMS data.  This was 
used to determine the concentration of cholesterol in homogeneous supported lipid 
membranes (Figure 2).   
 
Figure 2 TOF-SIMS used to quantify the amount of cholesterol in a membrane with varying 
cholesterol content.  
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Chapter 1 
Introduction 
Cell membranes are a composite of various lipids, carbohydrates, proteins and 
cholesterol.  They mediate many important interactions between a cell and its 
surroundings, including nutrient uptake, recognition and signaling.  In this thesis imaging 
secondary ion mass spectrometry is used for fundamental studies of cell membranes.  
In particular, 1) cell membrane organization (Chapters 2 and 3), 2) information about 
cell membrane composition is exploited for cell identification (Chapter 4) and 3) 
methods to quantify cholesterol concentration in model membranes are developed 
(Chapter 5).   
While once thought to be a well-mixed fluid structure,1 lateral variations in 
membrane composition are now believed to exist in the cellular plasma membrane.2  
Interactions between these components likely influence membrane organization, and 
ultimately, cellular function.  The non-random distributions of proteins in the membrane 
have been extensively studied because proteins perform many important biological 
processes, including material transport across the membrane and signal transduction.  
Fluorescent protein constructs have enabled proteins to be detected and visualized 
within the membranes of live cells using fluorescence microscopy.3 Meanwhile, highly 
specific gold-labeled antibodies permitted the high-resolution mapping of specific 
proteins in relation to morphological features that are visible with electron microscopy 
and revealed co-localization between different proteins.4  
 While protein-protein interactions are undoubtedly required for function, protein-
lipid and protein-cholesterol interactions may also be important.  One of the best-studied 
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biological processes that are believed to be influenced by membrane composition is 
influenza virus budding.  A large body of literature suggests that the influenza virus buds 
from the plasma membrane in regions that are enriched with sphingolipids and 
cholesterol, and changes in the concentrations of these components can adversely 
affect virus budding.5  Immunogold labeling and electron microscopy experiments have 
shown that hemagglutinin, an influenza envelope protein, clusters within small plasma 
membrane domains and this clustering is altered by cholesterol depletion.6 However, 
more direct evidence of local elevation in the cholesterol and sphingolipid abundances 
at the sites of hemagglutinin clustering has not been clearly established.  Cholesterol 
depletion also affects other cellular processes, including epidermal growth factor 
receptor transactivation by angiotensin II,7 cholecystokinin-stimulated signaling8 and the 
function of excitatory amino acid transporters.9  Similarly, changes in the amounts of 
sphingolipids in the membrane affect the fas receptor that is responsible for signaling 
cell death10 and signaling by the protein Mss4.11  These findings suggest that the 
quantity of specific lipids and sterols near certain membrane proteins influence function, 
yet the amounts of specific lipids and sterols near the membrane protein of interest 
remain largely unknown.  The development of high-resolution composition analysis 
methods that allow visualization of specific lipids, cholesterol and proteins of interest in 
parallel with sub-micron lateral resolution would greatly facilitate correlating cellular 
function with local membrane composition.  Such correlations in structure and function 
would aid in identifying the mechanisms by which membrane composition influences 
cellular function.   
 Imaging mass spectrometry is a promising approach to acquiring the location-
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specific chemical information that is relevant to membrane organization.  High-
resolution secondary ion mass spectrometry (SIMS) performed with the Cameca 
NanoSIMS 50 utilizes high-yielding atomic and diatomic secondary ions to identify the 
elemental and isotopic composition at the sample’s surface with a lateral resolution as 
high as 50 nm.12  A NanoSIMS has a limited number of detectors and, depending on the 
model, can only collect 5 or 7 mass-to-charge ratios (m/z).  In order to use a NanoSIMS 
to simultaneously image specific lipid species, cholesterol, and proteins of interest, 
which differ little in their elemental composition, each component must be selectively 
labeled with a rare stable isotope or non-native element that encodes for their identity.  
Developing a high-resolution SIMS approach performed on a NanoSIMS to evaluate the 
hypothesis that the major influenza virus envelope protein, hemagglutinin, colocalizes 
with cholesterol and sphingolipids in the plasma membrane would open the cell 
membrane for further analysis.  To accomplish this, orthogonal distinct isotopic or 
elemental labels must be incorporated into the cellular cholesterol, sphingolipids, other 
lipid species and influenza hemagglutinin to permit discrimination and detection using a 
NanoSIMS.   
 In mammalian cells, metabolic pathways for the lipid components of a cell 
membrane are well known and specific to particular species.  Proteins, on the other 
hand, are formed from various amino acids available within the cell, leaving no way to 
metabolically label a particular one of interest.  Rather, an immunolabel technique would 
provide the specificity required and allow greater flexibility with the identifying mass.  
This flexibility allows the stable isotopes 18O, 15N, 13C and other elements typically found 
in biomolecules to be reserved for metabolic labeling of various other membrane 
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components.   
 Spatial statistical analysis can provide insight into the organization of specific 
membrane components.  R, an open source programming language specifically built for 
statistical computing that is freely available under the general public license,13 is 
frequently used for this purpose.  There are several forms of R available, with most 
using a command line interface.  Many packages can be loaded to extend R’s 
functionality, including the spatstat package.  R is capable of handling very large data 
sets and can also link to C, C++ or Fortran code for even greater computational tasks. 
 While NanoSIMS has excellent lateral resolution, time-of-flight secondary ion mass 
spectrometry (TOF-SIMS) is a more common technique.  Here a pulsed ion beam 
sputters the surface, ejecting neutral and charged species consisting of multiple 
molecular fragments and even molecular ions; the charged species are directed to a 
time-of-flight mass analyzer.  This mass spectrum has a wealth of data that is unique to 
a particular species.  TOF-SIMS has imaging capability similar to the NanoSIMS 
although at a lower lateral resolution.  An advantage of using TOF-SIMS is the ability to 
use unlabeled material, allowing much simpler sample preparation.  While this 
technique does produce high-mass, chemically specific ions, they are typically in a low 
yield, making imaging with these species difficult.  A signal processing technique, such 
as multivariate analysis (MVA) of the higher yielding lower mass fragments can mitigate 
this issue14. 
 There are several methods of MVA that seek to reduce complex data to a few 
latent variables, which are linear combinations of variables that are mutually orthogonal.  
This data reduction reveals trends in variables or samples that would otherwise be lost 
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or suffer a loss of accuracy by examining each data channel individually.  Partial least 
squares regression (PLSR), specifically, maximizes both correlation to a particular 
variable and the capture spectral variance.  This method is therefore well suited for 
determining a concentration of an analyte in data with some variation within each 
sample. Partial least squares discriminant analysis (PLS-DA) is a simplified variant of 
PLSR that can be used when the prediction is binary.  
 The purpose of PLSR is to build a linear model Y=XB+E, where Y is a response 
matrix, X is the data matrix (n samples by p variables), B is a regression coefficient (p 
by n) and E is a noise term to account for any residual variation.  To apply different 
levels of importance to each variable the regression coefficient B, is further expressed 
as B=QW where Q is the matrix of regression coefficients, and W is a weighting matrix.  
The weighting and coefficient matrices are calculated using the SIMPLS algorithm15.  In 
this thesis, MVA of TOF-SIMS data is used to exploit chemical information encoded in 
the SIMS to identify the maturity stage of hematopoietic cells (Chapter 4) and to 
measure cholesterol concentration in lipid membranes (Chapter 5). 
 Directly studying a complex system like a cell membrane can be difficult, a much 
simpler model system, such as supported lipid membranes, can be used to study some 
important properties.16  Supported lipid membranes allow many different analytical 
techniques to be applied to them and are fairly stable when properly preserved.  Phase 
behavior, vesicle fusion and diffusion characteristics are among the properties studied 
with these systems.  Exposing a substrate to an aqueous solution of lipid vesicles can 
form these membranes.17  The lipid vesicles are attracted to the substrate, flatten and 
ultimately rupture creating a smooth membrane on the surface.17  These membranes 
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can be measured in liquid or flash-frozen and freeze-dried to be compatible with ultra-
high vacuum instrumentation.   
 In summary, both of these imaging surface mass spectrometry methods, 
NanoSIMS and TOF-SIMS, are useful in studying cell and model membrane 
composition and organization.  NanoSIMS allows greater imaging resolution, but 
requires distinct labeling of the species of interest and has a limited number of detectors 
and mass labels.  TOF-SIMS does not require mass labels and collects the entire mass 
spectrum, but offers lower imaging resolution and more complex spectra.  MVA 
processing of TOF-SIMS data can improve image contrast and greatly reduce the 
complexity of mass spectra.  Each technique will play a role in biologically relevant 
analysis.   
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Chapter 2 
Fluorinated colloidal gold immunolabels for imaging select proteins in parallel 
with lipids using high-resolution secondary ion mass spectrometry 
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Introduction 
 
To coordinate the numerous biological processes that occur at the cell’s surface, 
the plasma membrane is compartmentalized into compositionally and functionally 
distinct domains.2 Knowledge of component distribution in the plasma membrane 
facilitates identifying the mechanisms that underlie biological function. Given their key 
roles in biological processes, a number of labeling tools have been developed for 
detecting and imaging proteins. This includes genetically encoded fluorescent protein 
constructs and functionalized antibodies that can be detected with fluorescence or 
electron microscopy.3 Use of these labels has revealed certain membrane proteins 
cluster during cell signaling and virus budding, suggesting synergistic protein action may 
be a general mechanism that is common to membrane-mediated processes.4  
Though important, protein clustering is only one aspect of the plasma membrane 
organization that influences biological processes. The local abundances of cholesterol 
and certain lipid species, such as sphingolipids and phosphatidylethanolamine, near 
membrane proteins are also reported to affect protein function.4a, 4c, 5 To determine 
whether specific proteins are located within membrane domains that are enriched with 
particular lipid species, the protein and lipid species of interest must be visualized in 
parallel. However, imaging the lipid distribution in the plasma membrane is a significant 
challenge. The genetically encoded fluorescent tags and functionalized affinity labels 
that enable routine visualization of specific proteins with fluorescence or electron 
microscopy cannot be used to detect cholesterol or the majority of lipid species. 
Fluorescent lipid analogs can be visualized in parallel with membrane proteins labeled 
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with genetically encoded fluorescent tags, but only a fraction of the lipids of interest will 
bear fluorophores, and these fluorophores may alter the localization of the labeled lipid.6    
Secondary ion mass spectrometry (SIMS) is one of the few approaches for 
directly imaging the lipid organization in biological membranes without the use of 
fluorophores.7 During SIMS analysis, a primary ion beam desorbs neutral and ionized 
molecules and molecular fragments from the sample’s surface. The ionized species, 
which are called secondary ions, are analyzed by a mass spectrometer, and a mass 
spectrum of the molecules in the beam’s focal area is generated. By scanning the 
analysis beam across the sample and collecting the resulting secondary ions, the 
intensities of the component-specific secondary ions detected at each position can be 
used to construct a map of the sample’s surface composition. The distributions of lipids 
within cell membranes have been chemically imaged using time-of-flight SIMS (TOF-
SIMS).7b-d Because TOF-SIMS can detect intact and slightly fragmented molecular ions, 
this molecular imaging SIMS approach does not require labels to identify the parent 
molecule. However, TOF-SIMS imaging of distinct lipid microdomains in cell 
membranes has not yet been achieved, presumably due to limited sensitivity and spatial 
resolution. 
A SIMS instrument capable of mapping the isotopic and elemental composition at 
the sample surface with a lateral resolution as good as 50 nm (Cameca NanoSIMS 50) 
has enabled detecting and imaging submicrometer-size domains of isotopically labeled 
lipids in membranes.7g, 7i, 8 Because this instrument detects monoatomic and diatomic 
secondary ions, each species of interest must contain a distinct stable isotope so that 
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the secondary ions generated during NanoSIMS analysis can be linked to the parent 
molecule.7g The distinct stable isotopes that encode for component identity can be 
selectively incorporated into cholesterol and specific lipid species with established 
metabolic labeling techniques.9 However, because proteins share the same amino acid 
building blocks, metabolic labeling cannot be used to selectively tag specific proteins 
with the orthogonal distinct isotopes or non-native elements that would permit them to 
be imaged in parallel to lipids with a NanoSIMS.  
Existing approaches for selective protein labeling also have their limitations. 
Genetic methods for unnatural amino acid substitution10 must be repeated for every 
protein of interest. Immunolabels have broader applicability, and commercially available 
colloidal gold-functionalized immunolabels produce distinctive 197Au- secondary ions that 
can be used to detect specific proteins with a NanoSIMS. Nevertheless, colloidal gold-
functionalized immunolabels are not suitable for sensitive NanoSIMS detection in 
parallel with lipids. Specifically, the high magnetic field strength necessary to collect 
197Au- secondary ions with the magnetic sector mass spectrometer on the NanoSIMS 50 
precludes simultaneous detection of closely spaced masses, such as major and minor 
stable isotopes like 12C14N- and 12C15N-, 13C1H- and 12C1H-, and even 12C2- and 12C14N-. 
As a result, the 15N- and 13C-enrichment that is used to detect 15N- and 13C-labeled 
lipids, respectively cannot be imaged in parallel with the 197Au- ions. Therefore, to image 
197Au- and the lipid-related stable isotopic ratios, the magnetic field would have to be 
switched so that ions with different mass-to-charge ratios (m/z) could be consecutively 
collected on a detector. This approach reduces the measurement sensitivity because 
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the 197Au- and lipid-specific ions are continuously sputtered from the sample, but only a 
subset of each ion species is collected at any time.  As a result, few counts of each 
species is collected for a given depth of analysis, which in the case of the lipid 
membrane, is relatively shallow (<7 nm).  
Antibodies functionalized with a distinctive and low molecular weight isotope or 
element could permit imaging specific proteins in parallel to lipids with a NanoSIMS. 
Fluorine is an attractive candidate elemental label due to its low abundance in biological 
materials and high secondary ion yields.7g, 8a Methods to conjugate small fluorine-
containing molecules to antibodies have been developed for positron-emission 
tomography applications.11 However, we experimentally found that functionalizing 
antibodies with the high numbers of fluorinated molecules that enable sensitive 
detection with NanoSIMS compromised antibody binding.  
Here we report the development of a functionalized immunolabel for the detection 
of specific proteins in parallel with metabolically labeled lipids using NanoSIMS. The 
immunolabel consists of a colloidal gold nanoparticle that is functionalized with a 
partially fluorinated mixed monolayer and conjugated to a secondary antibody that 
permits selective protein labeling. The partially fluorinated mixed monolayer on the 
nanoparticle contains a large number of low mass, high yielding 19F- secondary ions, 
which permits highly sensitive NanoSIMS detection without compromising the 
simultaneous detection of lipid-specific secondary ions.7g, 8a As a proof of concept, we 
have used this immunolabel to detect and image influenza hemagglutinin in parallel with 
isotope-labeled lipids in the plasma membranes of cells with a NanoSIMS. 
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Hemagglutinin was selected as the protein of interest because its spatial organization in 
the membranes of transfected fibroblast cells is well-characterized.12 In this report, we 
image all cellular lipid species due to the ease of isotopically labeling them, and they 
permit demonstrating that the fluorinated gold immunolabels can be detected in parallel 
to the minor and major stable isotopes that are used to visualize the lipid-specific 
isotope enrichment with a NanoSIMS. 
Materials and methods 
Uniformly carbon-13 labeled algal fatty acids (98 atom% carbon-13) were from 
Cambridge Isotope Laboratories. N-hydroxysulfosuccinimide sodium salt (sulfo-NHS) 
was purchased from Prochem Inc. Hydrogen tetrachloroaurate(III) trihydrate (HAuCl4 • 
3H2O), Lipid-reduced fetal bovine serum (LR-FBS), and calf serum were from HyClone 
Laboratories. Poly-L-lysine and chemical fixation reagents were from Electron 
Microscopy Sciences. Fatty acid-free bovine serum albumin (BSA), goat anti-mouse 
polyclonal antibody, 13C18-steric acid (99 atom% carbon-13), and all other reagents were 
purchased from Sigma-Aldrich. Primary antibody (FC 125 anti-hemagglutinin developed 
in mouse) and the cell line that expresses influenza hemagglutinin (Clone 15 cell line) 
was the generous gift from Dr. Joshua Zimmerberg (Eunice Kennedy Shriver National 
Institute of Child Health and Human Development, National Institutes of Health, 
Bethesda, MD).  
Synthesis of Gold Nanoparticles  
2.9 mL (6.4 mmol) of oleylamine was dissolved in 49 mL of toluene and brought 
to a slow reflux. HAuCl4 • 3H2O (24.3 mg, 0.062 mmol) was dissolved in 1.2 mL (3.7 
mmol) of oleylamine and 1 mL of toluene. The gold solution was added to the refluxing 
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toluene solution, refluxed for 2 h, and cooled to room temperature. Particles were 
purified by precipitation with 100 mL of methanol and centrifugation at 3000 rpm for 20 
min. The particles were rinsed twice with methanol (50 mL) and dissolved in toluene (10 
mL), producing a bright red colloidal solution. 
Thiol Modification of Gold Nanoparticles  
A solution of gold nanoparticles in toluene (3 mL) was added to 1H,1H,2H,2H-
perfluorodecanethiol (8.5 µL, 0.029 mmol) in toluene (0.1 mL). After 2 min, 11-
mercaptoundecanoic acid (44.8 mg, 0.205 mmol) in toluene (0.4 mL) was added, 
resulting in a concentration of 8.3 mM 1H,1H,2H,2H-perfluorodecane thiol and 58.6 mM 
11-mercaptoundecanoic acid. The reaction was stirred at room temperature for 18 h. 
Excess thiols were removed by pelleting the particles by centrifugation, decanting the 
supernatant, and resuspending the particles in 1.5 mL toluene. After repeating this 
process three times, the particles were resuspended in 1 mL of DMSO and stored at 4 
°C. The particles were stable for at least one month under these conditions and did not 
exhibit irreversible flocculation.  
XPS of Nanoparticles  
XPS was performed on a Kratos Axis ULTRA with a monocromatic aluminum 
source, run at 150 w (15 kV) and spherical capacitor electron energy analyzer. The 
Kratos has a take-off angle of 90 degrees with respect to the sample plane with pass 
energies of 160 eV for surveys and 40 eV for high resolution. Spectra were calibrated 
using the carbon 1s peak at 285.0 eV.  XPS spectra were fitted using CasaXPS 
software. The analysis region was adjusted linearly for the background and each peak 
was fitted with a symmetrical Gaussian-Lorentzian function. The MUDA to PFDT ratio 
 16 
on the surface of the particles was quantified using the area under the carbon 1s peak 
at 288.1 eV from the terminal carbonyl on MUDA and the area under the carbon 1s 
peak at 292 eV from the PFDT CF2 moieties adjusted for the number of carbons. The 
extent that the carboxylic acids of MUDA were conjugated to lysine was quantified using 
the areas of the carbonyl peaks from the carboxylic acid on the unreacted MUDA and 
the conjugated lysine (288.5 eV) and the amide formed by lysine conjugation (288.1 
eV). Because each conjugated lysine residue contain one carboxylic acid, the area 
under the carboxylic acid peak that corresponded to fraction of unmodified carboxylic 
acids on MUDA was calculated by subtracting the area of the amide peak from the total 
area of the carboxylic acid peak. The ratio of the area of the carboxylic acid peak from 
the unmodified carboxylic acids on MUDA to the area of the amide peak formed by 
lysine conjugation was 0.068, indicating ~7% of the carboxylic acids on MUDA had not 
formed amide bonds with lysine. 
Qualitative Assessment of Nanoparticle Dispersibility in Aqueous Solution 
To evaluate the dispersal of the nanoparticles in aqueous media, the particles 
were pelleted by centrifugation, the toluene was decanted, and phosphate buffered 
saline (PBS) was added. After brief sonication, particle dispersal was visually assessed. 
Solutions of well-dispersed particles were red in color. Poor dispersibility of the particles 
was evidenced by the solution’s color changing from red to purple or blue, and the 
presence of particle precipitation.13 
Lysine Modification of Gold Nanoparticles  
Sulfo-NHS (44.0 mg, 0.205 mmol) and N,N’-dicyclohexylcarbodiimide (DCC) 
(59.3 mg, 0.287 mmol) were dissolved in 3 mL of DMSO and 0.68 mL of ethanol. Thiol-
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modified particles in DMSO (1 mL) were added to the sulfo-NHS and DCC solution and 
stirred for 3 h. Particles were pelleted by centrifugation, and resuspended in 1 mL of 
ethanol. Ethanol (4 mL) was added to lysine (1.68 g, 10.3 mmol) in 1.5 mL of water. 1 
mL of particles modified with sulfo-NHS in ethanol was added to the lysine solution and 
stirred overnight. Excess lysine was removed by pelleting the particles with 
centrifugation, decanting the supernatant, and resuspending the particles in deionized 
water. After repeating this process four times, the particles were stored at room 
temperature in water until protein conjugation. Particles stored under these conditions 
for one year did not exhibit irreversible flocculation. 
TOF-SIMS of Functionalized Nanoparticles  
A PHI Trift-III TOF-SIMS (Physical Electronics Incorporated, Chanhassen, MN) 
instrument with a 197Au+ liquid ion gun operated at 22 kV was used to collect positive-ion 
spectra in unbunched mode. The primary ion dose for each analysis was 3 x 1013 
ions/cm2. Twelve spectra were acquired from each set of thiol-functionalized 
nanoparticles. One of the twelve spectra of the nanoparticles modified with PFDT and 
MUDA (MUDA/PFDT-nanoparticles) was excluded from further analysis due to very low 
signal intensity. Each peak in a spectrum was normalized to the total intensity of all the 
peaks. Representative spectra were created by averaging the normalized intensities of 
the peaks in the 11 spectra of the MUDA/PFDT-nanoparticles and the 12 spectra of the 
nanoparticles that had lysine conjugated to the MUDA and PFDT monolayer 
(lysine/MUDA/PFDT-nanoparticles). 
Ovalbumin and Antibody Oxidation and Reaction with Nanoparticles 
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Ovalbumin (5 mg) was dissolved in 5 mL of 0.1 M Na2HPO4 buffer at pH 7.5. 20 
µL of 0.1 M NaIO4 was added to 200 µL of ovalbumin solution, inverted several times, 
and the oxidation was allowed to proceed for 30 min in the dark. 60 µL of goat anti-
mouse antibody solution (2.2 mg/mL) was desalted into 120 µL of 0.1 M Na2HPO4 
buffer at pH 7.5 using Amicon Ultra-4 10K centrifuge filters, producing desalted antibody 
at a concentration of 1.1 mg/mL. 12 µL of 0.1 M NaIO4 was added to the desalted 
antibody (120 µL), the reaction vial was inverted several times, and the oxidation was 
allowed to proceed for 30 min in the dark. A solution of oxidized goat anti-mouse 
polyclonal antibody (92.5 µL, 1.0 mg/mL) was added to 250 µL of lysine/MUDA/PFDT-
nanoparticles in water and gently shaken. After 5 min, 111 µL of oxidized ovalbumin 
solution was added to the particles, gently shaken, and incubated overnight. To remove 
unconjugated protein, the functionalized particles were diluted in 700 µL of 0.1 M 
Na2HPO4 buffer (pH 7.5) containing 2% BSA, the solution was centrifuged at 5000 rpm 
for 20 min, the supernatant was removed, and fresh 2% BSA in buffer was added. This 
process was repeated a total of six times.  
Evaluation of Aggregation of Antibody-Functionalized Particles with UV-Vis 
Absorbance measurements were performed on an Agilent 8453 UV-Visible 
Spectrophotometer. Antibody-functionalized particles were diluted 1:1 with 0.1 M 
Na2HPO4 buffer (pH 7.5), and filtered through a 0.1 µm syringe filter prior to 
measurement. Additional buffer was added to the functionalized gold immunolabel 
solution to obtain surface plasmon resonance absorbance below unity. 
ELISA Assay of Immunolabel Binding  
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Antibody binding affinity was assessed by ELISA using established protocols.14 
Individual wells in a microtiter plate (Dynex Technologies, Immulon  4HB) were filled  
with  50 µL of  2 µg/mL monoclonal antibodies to influenza hemagglutinin (FC-125 Gift 
from Dr. Joshua Zimmerberg, Eunice Kennedy Shriver National Institute of Child Health 
and Human Development, National Institutes of Health, Bethesda, MD). Negative 
control wells contained 50 µL of blocking buffer consisting of 0.25% IgG/ protease-free 
Bovine Serum Albumin (Jackson ImmunoResearch) in PBS containing 0.05% Tween 20 
(PBS-T). The plate was sealed and incubated for 2 h at 37 ºC in a CO2 incubator. The 
wells were emptied and washed three times with triple distilled water. Each 
experimental and control well was blocked with 400 µL of blocking buffer for 30 min on a 
plate shaker. Wells were washed and 50 uL of either Sigma-Aldrich goat Fc-specific 
anti-mouse IgG (positive control) or fluorothiolate-functionalized colloidal gold 
immunolabels (experimental) was added to the appropriate wells.  Dilutions were made 
to each sample in blocking buffer to achieve a protein concentration of approximately 
4.4 µg/mL based upon bicinchoninic acid assay (BCA assay) with an appropriate 
subtraction of BSA content in commercial samples. The plate was incubated for 3 h at 
room temperature with shaking. The wells were emptied and washed. Each 
experimental and control well was blocked with 400 µL of blocking buffer for 10 min at 
room temperature with shaking. The wells were emptied and washed again. 50 µL of a 
1:50,000 dilution of a tertiary antibody (Sigma clone GT-34 monoclonal sheep anti-goat 
IgG labeled with alkaline phosphatase) was added to each well and the plate was 
incubated for 2 h at room temperature with shaking. The wells were emptied, washed, 
blocked with 400 µL of blocking buffer on a plate shaker for 10 min at room 
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temperature, and washed. 75 µL of substrate solution containing 0.2 mM 4-
methylumbelliferylphospate (Sigma) in a solution of 50 mM Na2CO3 and 0.05 mM MgCl2 
was added to each well. The plate was covered and incubated on a plate shaker for 1 h 
at room temperature, and then read with a plate reader using a 365 nm excitation filter 
and a 450 nm emission filter. The plate was also read after 12 h. All results were 
expressed as a percentage of the positive control. 
Cell Culture  
Cells were grown in standard cell growth medium consisting of high glucose 
Dulbecco’s modification of Eagle’s medium (DMEM) supplemented with 10% calf serum, 
104 U/mL penicillin G, and 10 mg/mL streptomycin. Silicon substrates were placed in a 
cell culture dish when the cells were passaged and incubated overnight to permit cell 
attachment to the substrates. To metabolically label the cellular lipids with carbon-13, 
Clone 15 cells were passaged into DMEM supplemented with 1% calf serum, 10% LR-
FBS, 215 μM 13C-fatty acids (4:1:28 mass ratio of UL-13C- algal fatty acids/13C-stearic 
acid/fatty acid-free BSA), 50 μM cholesterol, and 20 μM ethanolamine. The growth 
medium was supplemented with 13C-fatty acid mixture and ethanolamine each day. On 
day 3, the cells were passaged. Cells (2 x106 cells) were cultured in dishes containing 
fresh medium, supplements, and sterilized and poly-L-lysine-coated 5 x 5 mm silicon 
substrates for one day.  
Analysis of 13C-Fatty Acid Incorporation  
Cells attached to the culture dish were used to assess the incorporation of 13C-
fatty acids into the cellular lipids. Cells were washed with PBS, detached from the dish, 
and collected via centrifugation. The lipids were extracted as reported,15 and saponified 
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with ethanolic KOH at 70 °C for 45 min. After acidification with HCl, the fatty acids were 
extracted into hexane and dried under N2 (g). The residue was dissolved in 
MeOH:CH2Cl2 (1:2), and reacted with 2 M trimethylsilyldiazomethane for 60 min. The 
composition of the resulting fatty acid methyl esters (FAME) was assessed with a 
GC/MS system consisting of an Agilent 7890 gas chromatograph, an Agilent 5975 mass 
selective detector and HP 7683B (Agilent Inc, Palo Alto, CA) autosampler. Gas 
chromatography was performed on a ZB-WAX (30 m × 0.25 mm I.D., 0.25 µm film 
thickness) capillary column (Phenomenex, Torrance, CA). Samples (1 µL) were injected 
in split mode (5:1) to the GC/MS system. The mass spectrometer was operated in 
positive electron impact mode at 69.9 eV in the m/z 50-800 scan range, which was used 
to detect six FAMES: C16:0, C16:1, C18:0, C18:1, and C18:2. Spectra were evaluated 
using the HP Chemstation (Agilent) program. Identification was performed using mass 
spectra obtained from authentic standards and additionally confirmed with NIST08 and 
W8N08 libraries (John Wiley & Sons, Inc., USA). 
Immunolabeling and Preservation  
Substrates with adherent cells were rinsed twice each with PBS with calcium and 
magnesium and Hendry's phosphate buffer (HPB), and fixed for 10 min with 2% 
paraformaldehyde and 0.05% glutaraldehyde in 0.1 M HPB. Cells were rinsed twice with 
HPB, once with PBS without calcium and magnesium (PBS -M), blocked with 
immunowash buffer (PBS -M with 1% BSA), and incubated with 15 µL of 0.18 mg/mL 
primary antibody for 30 min. Excess primary antibody was removed with by rinsing with 
immunowash buffer. The functionalized colloidal gold immunolabels were diluted 1:1 
with 0.1 M Na2HPO4 buffer (pH 7.5) and filtered with a 0.1 µm syringe filter. Samples 
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were incubated with 25 µL functionalized immunolabels for 30 min and rinsed twice with 
immunowash buffer and HPB. Cells were fixed with 4% glutaraldehyde in HPB for 30 
min, washed twice with HPB and once with water, post-fixed with 1% OsO4 for 15 min, 
rinsed three times with water, and air dried. Negative controls were prepared using 
immunowash buffer in place of the primary antibody. 
SEM 
Sample quality was assessed by imaging the cells at low magnification (500 – 
1100x) using a Hitachi 4800 SEM with 1 kV accelerating voltage. The immunolabels on 
the cells were imaged on a JEOL 7000F with 15 kV accelerating voltage using a 
backscatter detector.   
NanoSIMS Analysis  
To prevent sample charging during SIMS analysis, the samples were coated with 
~3 nm of iridium. While the depth of analysis employed in some of the following 
experiments did not exceed the thickness that the metal coating would be on an 
atomically flat surface, we empirically observed that the lipid-specific secondary ions in 
these experiments are detected at a more shallow sputtered depth than would be 
expected. We interpret this result to indicate that sample surface irregularity and 
metal/membrane mixing on a length scale below the lateral resolution of these SIMS 
measurements (<100 nm) leaves the lipid more exposed than the apparent metal 
coating would indicate. High resolution SIMS was performed on a NanoSIMS 50 
(Cameca, France) at Lawrence Livermore National Laboratory (Livermore, CA). 
Measurements were made with a 16 keV 133Cs+ primary ion beam. Confirmation that the 
fluorine signal located the functionalized immunolabels was performed using a ~1.37 pA 
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primary ion beam and simultaneously collecting the 19F- and 197Au- secondary ions and 
secondary electrons. Five replicate scans of 256 by 256 pixels with a dwell time of 1 
ms/pixel were acquired for each 20 by 20 µm2 analysis region, resulting in a pixel size of 
78 by 78 nm2 and a primary ion dose of 7.2 x 1014 ions/cm2. The analysis depth was 
approximately 3 nm, calculated as reported using the sputtering rate of 2.5 nm·μm2/pA·s 
that was determined on other biological samples.16 For the simultaneous imaging of the 
hemagglutinin protein and cellular lipids, the 12C1H-, 13C1H-, and 19F- secondary ions and 
secondary electrons were simultaneously collected using a ~0.264 pA primary ion beam. 
A mass resolving power of ~6,700 was used to separate isobaric interferences from the 
isotopes of interest. Four replicate scans of 256 by 256 pixels with a dwell time of 1 
ms/pixel were acquired for each 15 by 15 µm2 analysis region, resulting in a pixel size of 
59 by 59 nm2 and a primary ion dose of 1.9 x 1014 ions/cm2. Each analysis overlapped 
with the preceding analysis region in order to facilitate stitching the resulting NanoSIMS 
images together in a mosaic. Images were cropped to show the region that did not 
overlap with a preceding analysis region. We calculated an analysis depth of 
approximately 0.8 nm using the sputtering rate of 2.5 nm·μm2/pA·s for biological 
samples.16   
NanoSIMS Image Analysis  
A custom software package (L’image, L.R. Nittler, Carnegie Institution of 
Washington) run on the PV-Wave platform (Visual Numerics) was used to process the 
NanoSIMS data. 19F- images and 13C-enrichment images that show the distributions of 
the fluorothiolate-functionalized colloidal gold immunolabels that locate the influenza 
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hemagglutinin and the 13C- lipids, respectively, were constructed using a 3 x 3-pixel 
boxcar smoothing algorithm, producing images with 176 nm lateral resolution. The 13C-
enrichment images were constructed by ratioing the 13C1H- to the 12C1H- secondary ion 
counts collected at every pixel, and then dividing that ratio by the natural abundance 
ratio (0.011237). Ratioing the 13C1H- counts to the 12C1H- counts minimizes signal 
variations induced by sample topography, producing a quantitative measure of the local 
enrichment in 13C-labeled molecules compared to an unlabeled (natural abundance) 
cell.17 The resulting 13C-enrichment was color coded and mapped onto its 
corresponding pixel in the NanoSIMS image.  
Statistical analysis of NanoSIMS data  
In L’image, NanoSIMS images of the cell surface were divided into a grid of 1-
by1-pixel ROIs. The portion of the cell that overlapped with a previous NanoSIMS 
analysis was excluded. The 19F- counts and either the 197Au- counts or the carbon-13 
isotope ratio (13C1H-/12C1H-) and corresponding 13C-enrichment factor were determined 
for each ROI. The frequency distribution of the 19F- counts per pixel was expected to 
contain two populations: high counts at pixels where immunolabels were located, and 
low counts at pixels that lacked immunolabels. The MATLAB Statistics ToolboxTM for 
MATLAB (v.7.12.0.635 R2011a) was used to estimate the statistical parameters for 
these two populations. Because the variation in a large number (103 – 105) of SIMS 
measurements made on a homogeneous material is approximated by a Gaussian 
distribution18, we modeled the frequency distribution of 19F- counts with the best-fit 
probability density function (PDF) of a mixture of two unimodal normal distributions. 
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Note that comparison of these fits to those obtained with the best-fit Poisson distribution 
and mixture of two Poisson distributions confirmed that the mixture of two normal 
distributions was a better fit to the data. The threshold for the lowest counts/pixel that 
signifies a statistically significant elevation was calculated as the mean plus two 
standard deviations (μ1 + 2 s.d.1) for the population with the lower counts. The 
threshold for a statistically significant elevation in the 197Au- signal was determined with 
the same process. 
Results 
Synthesis of the fluorothiolate-functionalized colloidal gold immunolabel 
Our strategy for immunolabel synthesis involved functionalizing the colloidal gold 
nanoparticle with a partially fluorinated mixed monolayer, and then conjugating the 
fluorinated nanoparticle to secondary antibodies (Figure 2.1). We selected a 
bioconjugation strategy in which aldehydes are generated on the antibody’s 
glycosylated, non-binding, Fc region for covalent reaction with amines on the 
nanoparticle, yielding a stable linkage that does not obstruct antibody binding.13b To 
permit antibody attachment and to help render the particles dispersible in aqueous 
buffers, the thiols in the partially fluorinated mixed monolayer on the colloidal gold 
nanoparticle should have a chain length longer than seven methylene units and be 
capped with an ionizable amine moiety.13a,19 Because amine-terminated 
perfluoroalkanethiols of sufficient length were not commercially available, we created a 
mixed monolayer that consisted of a fluorinated alkane thiol (1H,1H,2H,2H-
perfluorodecanethiol, PFDT) for NanoSIMS detection, and a carboxylic-acid-terminated 
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thiol (11-mercaptoundecanoic acid, MUDA) that could be converted to an ionizable 
terminal amine by reaction with lysine.20 We anticipated that the hydrophobic PFDT 
component might induce the resulting functionalized nanoparticles to flocculate in water, 
as might be nanoparticles modified with a PFDT monolayer are not dispersible in 
aqueous solvent mixtures.21 However, the presence of an ionizable terminal moiety on 
the capping monolayer promotes nanoparticle dispersibility in water,13a,19 so we 
hypothesized that the ratio of MUDA to PFDT in the monolayer could be adjusted to 
produce water-dispersible and partially fluorinated nanoparticles.  
 
 
Figure 2.1 Synthesis of functionalized immunolabel consisting of an antibody attached 
to a gold nanoparticle (20-nm-diameter) functionalized with a partially fluorinated mixed 
monolayer. The gold nanoparticle is capped with a mixed monolayer composed of 
fluorinated and carboxylic acid-terminated thiols. The carboxylic acids are condensed 
with lysine, producing ionizable terminal amines. Aldehydes are generated on the 
glycosylated Fc region of the antibody and the glycosylated portions of the blocking 
protein, ovalbumin (not shown), by mild oxidation with sodium periodate. Reaction of the 
aldehydes on the antibody and ovalbumin with the amines on the fluorinated 
nanoparticles produces a stable linkage that does not interfere with antibody binding. 
 
Gold nanoparticles with an average diameter of 20 nm were synthesized using 
oleylamine to reduce Au3+ in toluene.22 This nanoparticle size is a compromise between 
large particles that facilitate secondary characterization of cell labeling with SEM, and 
smaller particles that typically have higher immunolabeling efficiency.23 To identify the 
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reaction conditions that produced water-dispersible and fluorinated nanoparticles, we 
varied the molar ratio of MUDA to PFDT between 1:10 and 10:1, and assessed the 
particles’ fluorine content and dispersibility in aqueous buffer. XPS measurements 
indicated that MUDA to PFDT ratios of 1:10 and 1:1yielded fluorinated colloidal gold 
nanoparticles, but fluorine was not detected on the nanoparticles modified with a 10:1 
ratio of MUDA to PFDT (Table 2.1). Nanoparticle dispersibility in aqueous buffer 
followed the opposite trend; only the nanoparticles modified with a 10:1 ratio of MUDA 
to PFDT exhibited adequate dispersion in PBS, signified by the solution’s red color. The 
poor dispersibility of particles modified with 1:1 and 1:10 ratios of MUDA to PFDT was 
evident from the solution’s color changing from red to purple or blue, and visible particle 
precipitation.13 Subsequent investigations of MUDA to PFDT ratios between 1:1 and 
10:1 indicated that a 7:1 ratio reproducibly produced water-dispersible and partially 
fluorinated nanoparticles when PFDT was allowed to react with the colloidal gold for 2 
minutes prior to MUDA addition (Table 2.1). Finally, amine functionalities were 
generated on the surface of the nanoparticles that had been functionalized with a 
partially fluorinated mixed monolayer (MUDA/PFDT-nanoparticles) by condensing the 
terminal carboxylic acids on the monolayer with lysine.  
Table 2.1 Fraction of PFDT in the Monolayers on Gold Nanoparticles That Were 
Modified with Various Ratios of MUDA:PFDT Measured with XPS 
*MUDA was added 2 min after the addition of PFDT (see text for details).  
  
MUDA:PFDT ratio in 
reaction mixture 10:1 
7:1 with 
delay† 1:1 1:10 
Number of samples 
analyzed 4 6 6 4 
Mean fraction of PFDT in 
monolayer ± 1 s.d. 0 ± 0 0.16 ± 0.11 0.22 ± 0.07 0.54 ± 0.10 
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The presence of lysine on the surface of the MUDA/PFDT-nanoparticles that had 
been reacted with lysine (lysine/MUDA/PFDT-nanoparticles) was verified with three 
methods. First, a fluoresceinamine-based colorimetric test confirmed the presence of 
primary amines that are characteristic of lysine on the lysine/MUDA/PFDT-nanoparticles, 
but not on the unmodified MUDA/PFDT-nanoparticles (Figure 2.2). Second, comparison 
of the XPS spectra of lysine/MUDA/PFDT-nanoparticles and MUDA/PFDT-nanoparticles 
demonstrated the presence of chemical bonds distinctive of lysine conjugation to the 
nanoparticles (Figure 2.3).  
 
Figure 2.2 Colorimetric test for primary amines on lysine/MUDA/PFDT-nanoparticles. 
The presence of lysine on the functionalized nanoparticles was qualitatively tested by 
the addition of fluoresceinamine, which rapidly reacts with primary amines and forms a 
fluorescent product. The fluorescence that resulted from the addition of 
fluoresceinamine to a vial containing asolution of lysine/MUDA/PFDT-nanoparticles 
confirms the presence of lysine on the particles (vial on right). In comparison, 
florescence was not detectable when flouoresceinamine was added to a solution of 
MUDA/PDFT-nanoparticles that had not been reacted with lysine (vial on left).  
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Figure 2.3 Nitrogen 1s XPS spectrum of lysine/MUDA/PFDT-nanoparticles. The 
appearance of peaks at 399.4 eV (C-NH2) and 401.3 eV (N-C=O) confirm the presence 
of the amine and amide bonds that are characteristic of lysine coupling. 
 
Specifically, the nitrogen 1s peaks at 399.4 eV (C-NH2) and 401.3 eV (N-C=O) that 
appeared in the XPS spectra of lysine/MUDA/PFDT-nanoparticles (Figure 2.4A and 
Figure 2.3) are indicative of the amines on the lysine residue and the formation of an 
amide bond with lysine, respectively.  Additionally, the increase and shift in the carbonyl 
peak’s maxima from 288.8 eV in the MUDA/PFDT-nanoparticle spectra to 288.3 eV in 
the lysine/MUDA/PFDT-nanoparticle spectra signified the presence of the carboxylic 
acid on lysine and amide bond formation (Figure 2.4B and 2.4C). Furthermore, the 
shoulder at 286.4 eV that appeared in the lysine/MUDA/PFDT-nanoparticle spectra is 
characteristic of the C-N single bonds in lysine (Figure 2.4C). Based on deconvolution 
of the carbonyl peak shown in Figure 2.4C into separate carboxylic acid and amide 
peaks, more than 90% of the MUDA carboxylic acids were covalently attached to lysine. 
Third, comparison of TOF-SIMS spectra of lysine/MUDA/PFDT-nanoparticles and 
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MUDA/PFDT-nanoparticles demonstrated that lysine was covalently attached to the 
lysine/MUDA/PFDT-nanoparticles. 
 
 
Figure 2.4 XPS spectra of lysine/MUDA/PFDT-nanoparticles and MUDA/PFDT-
nanoparticles. (A) Survey scan lysine/MUDA/PFDT- nanoparticles (red) and 
MUDA/PFDT-nanoparticles (blue) shows that lysine modification induced the 
appearance of the nitrogen 1s peaks at ∼400 eV due to the amine and amide bonds 
that are characteristic of lysine coupling. (B) The photoelectron spectra (blue) of the 
carbon 1s scan acquired from the MUDA/PFDT-nanoparticles was fit with the following 
carbon peaks: CF2 (291.5 eV), COOH (288.8 eV), C−S (286.1 eV), and CH2 (285.0 eV). 
(C) The photoelectron spectra (red) of the carbon 1s scan acquired from the 
lysine/MUDA/PFDT- nanoparticles was fit with the following carbon peaks: CF2 (291.5 
eV), COOH (288.5 eV), CONH (288.1 eV), C−N (286.5 eV), C−S (286.1 eV), and CH2 
(285.0 eV). 
 
Representative positive ion spectra of lysine/MUDA/PFDT-nanoparticles and 
MUDA/PFDT-nanoparticles are shown in Figure 2.5, where a range from m/z 1 to 300 
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is shown because ions with m/z >300 have low detection efficiency with our TOF-SIMS 
instrumentation. Peaks that most likely correspond to gold (m/z 197), fluorinated PFDT 
fragment ions (m/z 69, 268, and 300 from CF3+, C5F11+, and C6F12+, respectively), and 
MUDA fragment ions (m/z 41, 55, 243, and 296 from C3H5+, C4H7+, CH2SAu+, and 
C5H7SAu+, respectively) were visible in the spectra of the MUDA/PFDT-nanoparticles 
(Figure 2.5A). Additional peaks that likely correspond to lysine fragment ions (m/z 56, 
and 84 from C3H6N+ and C5H9N+, respectively)24 and the sodium adduct of a lysine-
amide fragment ion (m/z 224 from C9H17N2O3Na+) were present in the spectra of the 
lysine/MUDA/PFDT-nanoparticles (Figure 2.5B). Although peak m/z 147 is often 
attributed to lysine,24 its co-appearance with peak m/z 73 in the lysine/MUDA/PFDT-
nanoparticle spectra may instead indicate the presence of polydimethylsiloxane, a 
common surface contaminant.25 Peaks with m/z between 200 and 300 that correspond 
to MUDA and PFDT fragment ions are not present in the lysine/MUDA/PFDT-
nanoparticle spectra, possibly due to the suppression of these ions by the more basic 
lysine residues.26 Altogether, these experiments confirm that lysine had been covalently 
attached to the MUDA/PFDT-nanoparticles.  
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Figure 2.5 Represntative positive ion TOF-SIMS spectra of (A) MUDA/PFDT-
nanoparticles and (B) lysine/MUDA/PFDT-nanoparticles. 
 
Immunolabel synthesis was completed by attaching the fluorinated nanoparticles 
to secondary antibodies. We desired to limit the amount of antibody conjugated to each 
fluorinated colloidal gold nanoparticle in order to prevent cross-linking the antigens on 
the cell surface, but low protein coverage induces nanoparticle aggregation.13b To obtain 
the high protein surface coverage that stabilizes the nanoparticles in buffered solution 
without increasing the antibody loading, we first reacted the nanoparticles with a small 
amount of oxidized antibody, and then blocked the nanoparticle surface with ovalbumin, 
a small, glycosylated protein. This was accomplished by mildly oxidizing the polyclonal 
goat anti-mouse antibodies and ovalbumin with sodium periodate, generating reactive 
aldehyde moieties on the glycosylated regions of the proteins.13b These aldehydes were 
then reacted with the amines on the functionalized nanoparticles under non-denaturing 
conditions. The resulting fluorothiolate-functionalized colloidal gold immunolabels 
exhibited a UV-vis absorption maximum at ~525 nm (Figure 2.6), indicating the 
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absence of nanoparticle aggregation.13b The affinity and selectivity of the immunolabels 
to their antigen, mouse antibody, was confirmed with ELISA.  
 
Figure 2.6 UV-Vis spectrum of antibody-functionalized nanoparticles. The local 
maximum at ~525 nm in the UV-vis absorption spectra of the antibody-functionalized 
fluorinated nanoparticles in 0.1 M Na2HPO4 buffer (pH 7.5) confirms the absence of 
aggregation. 
 
Verification of cell labeling with fluorothiolate-functionalized colloidal gold 
immunolabels  
We evaluated the detection of the fluorothiolate-functionalized colloidal gold 
immunolabels that located specific proteins on cells with scanning electron microscopy 
(SEM) and high-resolution SIMS performed with a NanoSIMS 50. As stated in the 
Introduction, we focused on the detection of influenza hemagglutinin in the plasma 
membranes of transfected fibroblast cells (Clone 15 cell line) in these experiments 
because the spatial organization of this protein is well-characterized.12 Influenza 
hemagglutinin in the plasma membranes of Clone 15 cells was selectively labeled with a 
mouse anti-hemagglutinin monoclonal primary antibody, followed by the fluorothiolate-
functionalized colloidal gold immunolabels. The cells were chemically fixed and imaged 
with SEM (Figure 2.7) and NanoSIMS (Figure 2.9). As a negative control experiment, 
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we also used SEM to image a Clone 15 cell that was not labeled with primary antibody 
prior to exposure to the fluorothiolate-functionalized colloidal gold immunolabels 
(negative control).  
 
 
Figure 2.7 SEM images of immunolabeled cells taken in BSE mode. Elements with high 
atomic weight, such as gold, appear bright in BSE images, which allows unambiguous 
identification of the functionalized colloidal gold immunolabels. (A) The fluorinated 
colloidal gold immunolabels visible on the cell surface locate the influenza 
hemagglutinin protein. The immunolabels were often arranged in two-dimensional 
clusters on the cell surface that are similar to the previously reported clusters of colloidal 
gold immunolabels that locate hemagglutinin, and are indicative of hemagglutinin 
clustering within the plasma membrane.37, 38 (B) A larger region of the surface of the 
negative control cell was imaged to acquire an overview of the extent of nonspecific 
labeling. Few individual fluorinated gold immunolabels (closed arrows) and two very 
small immunolabel clusters (open- arrow) were detected on the Clone 15 cell that was 
not tagged with primary antibody prior to exposure to the fluorothiolate-functionalized 
colloidal gold immunolabels (negative control). The small amount of label present on the 
negative control sample indicated that little nonspecific binding occurred.  
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SEM imaging was performed using backscattered electron (BSE) mode to permit 
unambiguous detection of the colloidal gold nanoparticles, as elements with high atomic 
weight, such as gold, appear bright in BSE images. The fluorothiolate-functionalized 
colloidal gold immunolabels that located the influenza hemagglutinin were clearly visible 
on the surface of the immunolabeled cell (Figure 2.7A). Though individual gold 
nanoparticles were present, the majority of the immunolabels were clustered in two 
dimensions on the cell surface. This two-dimensional clustering of the colloidal gold 
immunolabels that locate hemagglutinin has been previously reported by others, and it 
is indicative of hemagglutinin accumulation within small domains in the plasma 
membrane.12 In contrast, large immunolabel aggregates, such as those that occur when 
ovalbumin is not used to block the surfaces of the nanoparticles (Figure 2.8), are 
significantly larger and have a three-dimensional appearance. Thus, the two-
dimensional clusters of fluorothiolate-functionalized colloidal gold immunolabels that we 
observed on the immunolabeled cell were indicative of hemagglutinin’s native clustered 
distribution in the cell membrane, and not immunolabel aggregation. Noteworthy, very 
few individual particles (Figure 2.7B, closed arrows) or immunolabel clusters (Figure 
2.7B, open arrows) were visible on the negative control Clone 15 cell that was not 
labeled with primary antibody prior to treatment with the functionalized immunolabels. 
Thus, very little nonspecific binding occurred. 
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Figure 2.8 SEM and NanoSIMS images of aggregated immunolabels. (A) SEM image 
acquired prior to NanoSIMS analysis reveals large three-dimensional aggregates of 
colloidal gold immunolabels on an immunolabeled Clone 15 fibroblast cell. This 
occurred because the surfaces of the nanoparticles were not blocked with ovalbumin; 
inadequate protein coverage induces nanoparticle aggregation. (B) Secondary electron 
(SE) and (C) 19F- ion images acquired with NanoSIMS. Local elevations in the 19F- ion 
signal are produced by the fluorinated gold particles attached to antibodies. Comparison 
between these images confirms that the aggregates of fluorothiolate-functionalized 
colloidal gold immunolabels are visible in the secondary electron images. Unaggregated 
nanoparticles are not visible in the secondary electron NanoSIMS image because they 
are smaller than the lateral resolution of the NanoSIMS measurement. 
 
Four regions on an immunolabeled Clone 15 fibroblast cell were analyzed with 
NanoSIMS to confirm that the fluorine secondary ion signal could be used to detect the 
fluorothiolate-functionalized colloidal gold immunolabels. NanoSIMS analysis was 
performed on cells that had not been imaged with SEM in backscattered electron mode 
because our earlier experiments indicated that electron impact at >5 kV during 
backscatter imaging decomposed the fluorinated alkane thiols on the nanoparticles. As 
shown below, SEM imaging performed at low magnification with low voltage (≤5 kV), 
however, permitted both evaluation of cell preservation7l and NanoSIMS detection of the 
fluorinated alkane thiols. A representative NanoSIMS secondary electron image that 
was acquired in parallel to the secondary ion images shows the morphology of the 
immunolabeled cell (Figure 2.9A). Individual nanoparticles are not visible in the 
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secondary electron image because the nanoparticles were smaller than the lateral 
resolution of this NanoSIMS analysis (approximately 100 nm). The inability to detect 
nanoparticle aggregates in this image indicates that large (≥100 nm) aggregates of the 
functionalized immunolabels were not present. However, local elevations in the 
immunolabel-specific 197Au- and 19F- secondary ions are clearly visible in the NanoSIMS 
secondary ion images (Figures 2.9B and 2.9C, respectively). The local elevations in the 
197Au- and 19F- secondary ions varied in intensity and often had multi-pixel dimensions, 
which suggests they represent the two-dimensional clusters of differing numbers of 
individual immunolabels that we observed with SEM. Statistical analysis of the ion signal 
intensities detected at 60,180 1-by-1-pixel subregions within the representative region 
that corresponded to the surface of the cell indicated that 19F- and 197Au- ion counts/pixel 
greater than 32 and 18, respectively, were statistically significant local elevations. As 
implied by the overlay of the 197Au- and 19F- ion images (Figure 2.10), this statistical 
analysis also confirmed that the 197Au- and 19F- ion signals were positively correlated 
(correlation coefficient = 0.87 at 95% confidence interval). The 197Au- and 19F- ion 
signals detected on the cell surface at the three other analysis regions were also 
positively correlated (correlation coefficients = 0.83, 0.67, and 0.86 for 42,262, 56,911, 
and 50,138 1-by-1-pixel regions, respectively, at 95% confidence interval), confirming 
that the 19F- signal was produced by the fluorothiolate-functionalized colloidal gold 
immunolabels. Altogether, these results demonstrate that the functionalized 
immunolabels could be detected with NanoSIMS via local elevations in the 19F- or 197Au- 
secondary ions.  
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Figure 2.9 NanoSIMS images were acquired of a 15 by 15 μm2 region on a Clone 15 
cell that was labeled with fluorothiolate-functionalized colloidal gold immunolabels that 
bound to the primary antibodies against the influenza hemagglutinin within the plasma 
membrane. (A) The secondary electron (SE) image shows cell morphology. The 
fluorothiolate-functionalized colloidal gold immunolabels are not visible in the secondary 
electron image because they were smaller than the lateral resolution of the NanoSIMS 
analysis (∼100 nm). The lack of nanoparticle aggregates visible in the SE image 
demonstrates the absence of large (≥100 nm) aggregates of immunolabels. (B) The 
197Au− ion image shows the distribution of the fluorinated colloidal gold immunolabels on 
the cell surface. (C) The 19F− ion image also revealed the locations of the fluorinated 
colloidal gold immunolabels on the cell surface. As expected, the 197Au− and 19F− 
secondary ions were colocalized in the image, indicating that both secondary ion 
species located the influenza hemagglutinin on the cell surface. 
 
 
 
Figure 2.10 Composite 19F-, 197Au-, and secondary electron image of cell. The 19F- (red), 
197Au- (green), and secondary electron NanoSIMS images that are shown in Figure 2.9 
were overlaid to permit visual assessment of signal colocalization. Regions with local 
elevations in both the 19F- (red) and 197Au- (green) secondary ion signals appear yellow. 
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Simultaneous imaging of influenza hemagglutinin and all cellular lipid species in 
the cell membrane  
Next, we assessed the ability to image the fluorothiolate-functionalized colloidal 
gold immunolabels that locate hemagglutinin in the plasma membranes of Clone 15 
cells in parallel with lipids using a NanoSIMS. Again, we chose to image all cellular lipid 
species due to the ease of incorporating commercially available uniformly 13C-labeled 
fatty acids into cellular lipids, and the resulting 13C-lipids permitted demonstrating that 
the 13C1H- and 12C1H- ions used to measure the lipid-specific 13C-enrichment could be 
simultaneously detected with the fluorinated immunolabels. The Clone 15 cells we 
studied had been metabolically labeled such that approximately 55% and 90% of the 
fatty acids in the cellular glycolipids and sphingomyelin, respectively, were uniformly 
carbon-13 labeled prior to tagging the influenza hemagglutinin with the fluorinated 
immunolabels. As a negative control, we also analyzed metabolically labeled Clone 15 
cells that were not exposed to primary anti-hemagglutinin antibody prior to the 
fluorothiolate-functionalized colloidal gold immunolabels. We imaged the fluorothiolate-
functionalized colloidal gold immunolabels and 13C-lipids in parallel by using NanoSIMS 
to simultaneously collect the 19F-, 13C1H- and 12C1H- secondary ions. To minimize the 
fraction of secondary ions collected from the cytoplasm, NanoSIMS was performed with 
a lower primary ion dose than that used to evaluate immunolabel detection, resulting in 
a reduced secondary ion signal intensity compared to those obtained in Figure 2.9.  
The secondary electron, 19F- ion, and 13C-enrichment NanoSIMS images shown 
in Figure 2.11 are representative examples of the >50 other regions that we analyzed 
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on five different cells (prepared on 2 separate days). Neither individual nanoparticles nor 
nanoparticle aggregates are visible in the NanoSIMS secondary electron images, 
confirming that large (≥100 nm) immunolabel aggregates were not present on the cells 
(Figure 2.11A and 2.11D). The locations of the hemagglutinin in the membrane are 
revealed by the regional elevations in the 19F- secondary ion counts that are visible in 
the representative NanoSIMS 19F- ion images of the immunolabeled cell (Figure 2.11B). 
Analysis of 79,596 1-by-1-pixel ROIs that corresponded to regions on the surface of the 
immunolabeled cell that did not overlap with a preceding NanoSIMS measurement 
indicated that 19F- counts/pixel greater than 3 were statistically significant local 
elevations. In comparison, very little non-specific labeling occurred on the negative 
control cell, as evidenced by the low number of pixels in which the 19F- secondary ion 
count exceeded unity (Figure 2.11E).  The distribution of 13C-lipids in the membrane of 
the immunolabeled and negative control cell are shown by the quantitative 13C-
enrichment images (Figure 2.11C and 2.11F) that were acquired in parallel to the 19F- 
ion images. The lateral variations in the 13C-enrichment within the membrane suggest 
that the 13C-lipids are unevenly distributed on the surface of both cells. Projection of the 
individual ion images onto the secondary electron image indicates that neither the 
immunolabels nor the 13C-lipid distributions were correlated with cell topography (Figure 
2.12A, 2.12B, 2.12D, and 2.12E). Similarly, the overlay of the 19F- ion and 13C-
enrichment NanoSIMS images (Figure 2.12C and 2.12F) indicates the immunolabels on 
the experimental cell were not co-localized with lipid-enriched or lipid-depleted regions 
of the membrane. 
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Figure 2.11 Mosaic of overlapping NanoSIMS images that were acquired on 
immunolabeled and unlabeled (negative control) Clone 15 cells that contained 
metabolically incorporated 13C-lipids. (A) Secondary electron (SE) images show the 
morphology of the surface of the immunolabeled Clone 15 cell. (B) The 19F− NanoSIMS 
images acquired in parallel with the secondary electron (A) and 13C-enrichment (C) 
images reveal the location of influenza hemagglutinin in the membrane of the 
immunolabeled cell. (C) The 13C-enrichment images show the distribution of 13C-lipids in 
the plasma membrane of the immunolabeled Clone 15 cell. (D) Secondary electron 
images of the surface of the negative control cell were acquired in parallel with 19F− and 
13C-enrichment images. (E) Few nonspecifically adsorbed immunolabels were present 
on the negative control Clone 15 cell. (F) The 13C-enrichment images confirmed that 
13C-lipids were present in the plasma membrane of the negative control Clone 15 cell. 
 
The lack of a correlation between the 19F- counts and the 13C-enrichment on the 
experimental cell was confirmed by statistical analysis (correlation coefficient = -0.03 at 
the 95% confidence interval). The absence of a significant negative correlation between 
the immunolabel- and lipid-specific secondary ion signals indicates the immunolabels 
did not hinder the detection of the underlying membrane. Overall, these imaging data 
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demonstrate the ability to directly visualize the distribution of a specific protein, influenza 
hemagglutinin, with respect to membrane lipids and cell surface morphology. 
 
Figure 2.12 Composite 19F-, 13C-enrichment, and secondary electron images of cells. 
The 19F- ions (red), 13C-enrichment (blue), and secondary electron NanoSIMS images 
that are shown in Figure 2.8 were overlaid to permit visual assessment of signal 
colocalization (A, D) Projection of the 19F- secondary ion signals (red) onto the 
NanoSIMS secondary electron image shows that the fluorothiolate-functionalized 
colloidal gold immunolabels are not located at structurally distinct features on the cell 
surface. (B, E) Overlay of the 13C-enrichment image (blue) onto the NanoSIMS 
secondary electron image shows that the regions that contain elevated levels of 13C-
lipids occasionally occur at protrusions on the cell surface. (C, E) Overlay of the 19F- 
secondary ion signals (red) on the 13C-enrichment image (blue) reveals the 
fluorothiolate-functionalized colloidal gold immunolabels are not correlated with the 
regions of elevated 13C-lipid abundance. Refer to Figure 2.11 for signal intensities.  
 
Discussion and conclusion 
In a previous study, we used NanoSIMS to image the lipid distribution within 
phase-separated model membranes with high lateral resolution.7i Here, we extended 
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NanoSIMS analysis to simultaneously imaging all cellular lipid species and influenza 
hemagglutinin within the plasma membranes of intact cells by developing new fluorine-
functionalized antibodies that permit selective protein detection in parallel with lipid-
specific isotopes. This demonstration provides a general framework for simultaneously 
imaging distinct proteins and lipid species within the plasma membranes of cells with 
high sensitivity and lateral resolution. Because secondary antibodies are used to create 
the immunolabels, any protein of interest can be detected and imaged simply by 
employing the corresponding primary antibody. Though we imaged all of the cellular 
lipid species here as a proof of concept, the distribution of a protein of interest with 
respect to more specific lipid species may be achieved by employing established 
methods to incorporate distinct stable isotopes into phosphatidylethanolamine,27 
cholesterol,9a sphingolipids,9b or gangliosides.9c This approach may reveal whether the 
protein of interest is located within a membrane domain that is enriched with a particular 
lipid species when it is combined with cell preparation methods that do not induce 
reorganization of the lipid species.7l 
Our immunolabel synthesis strategy was optimized to permit sensitive NanoSIMS 
detection and broad applicability. A key feature of the immunolabel design is that the 
fluorinated moieties were not directly attached to the antibody. Conjugation of the 
antibodies to gold nanoparticles that were capped with a partially fluorinated mixed 
monolayer permitted functionalizing the antibody with a high number of fluorine atoms 
without loss of binding. The strategy for immunolabel synthesis can be easily modulated 
to further broaden immunolabel applicability. For example, immunolabels that permit 
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additional proteins to be detected in parallel to those labeled with fluorinated colloidal 
gold immunolabels can be fabricated by functionalizing the colloidal gold with alkane 
thiols that contain other non-native elements (i.e., bromine) or stable isotopes (i.e., 
deuterium or nitrogen-15). Immunolabels with smaller gold nanoparticles may be 
desirable for reduction of the steric hindrance between probes that may occur during the 
labeling procedure.28 Such immunolabels may be created by employing the Brust 
method for nanoparticle synthesis.29 We expect the label-specific secondary ions 
produced by smaller immunolabels will also be detectable by NanoSIMS even though 
these gold nanoparticles will be too small to be resolved in the NanoSIMS secondary 
electron images.   
Use of the fluorothiolate-functionalized colloidal gold immunolabels described 
herein with metabolic incorporation of distinct stable isotopes and NanoSIMS analysis 
will facilitate the testing of predictions that specific membrane proteins are located within 
distinct lipid environments. By combining this approach to imaging membrane 
components with complementary assays of protein function, the role of the local lipid 
composition on protein function might also be elucidated. 
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Chapter 3 
 
Statistical analysis of high-resolution secondary ion mass spectrometry images 
of sphingolipids and influenza hemagglutinin 
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Introduction 
 Proteins have been known to have a non-random distribution on cell 
membranes.1  There is also evidence that distinct lipid species are organized into 
domains that may be associated with particular proteins.2  In one hypothesis, domains 
enriched with cholesterol and sphingolipids, which are called lipid rafts, preferentially 
associate with certain proteins.3  Favorable interactions between the cholesterol and/or 
sphingolipids and the membrane proteins are thought to be the driving force for this 
behavior.4  One highly studied system is the association of the influenza membrane 
protein, hemagglutinin, and lipid rafts.  Detergent extractions and the composition of 
virus envelopes have implied that hemagglutinin and lipid raft components, namely 
sphingolipids and cholesterol, are colocalized on the cell membrane.5  While 
hemagglutinin was observed to be non-randomly located in electron dense domains 
using electron microscopy, and these electron dense lipid domains were postulated to 
be lipid rafts,6 directly assessment of the local lipid environment has been out of reach.  
A direct imaging method, such as described in Chapter 2, would allow the arrangement 
of lipid species and proteins of interest to be evaluated with spatial statistics.   
The NanoSIMS generates a plane of mass intensities resulting from the 
structures on the sample.  Proteins, such as hemagglutinin, often have varying levels of 
clustering or organization over the length scales permitted in NanoSIMS analysis.6  If 
domains enriched with sphingolipids and cholesterol are associated with hemagglutinin 
in the membrane,  one would expect that the sphingolipids would exhibit an organization 
that is similar to that of hemagglutinin in the cell .7  Spatial statistics, which can show 
patterns in complicated data and generate a concrete understanding that would 
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otherwise be missed with observation alone, will indicate if this hypothesis is correct.  
The spatial statistics package, spatstat,8 is an extension of the R statistical 
programming environment.  Spatstat is mainly used for examining spatial point patterns 
in any two-dimensional region, though it is also capable of higher-dimensional pattern 
analysis.  Among the over 1000 functions included are plotting spatial data, random 
data simulation, and sampling methods.  Several exploratory methods, including 
Ripley's K function, pair-wise distance, nearest neighbor distance are available for point 
pattern analysis.  These features make it and ideal platform for exploring NanoSIMS 
data. 
 There are several pieces of required information and considerations when 
analyzing spatially distributed data.  As expected, the position of the features is the 
focus of the analysis.  These locations in x-y space will determine nearest neighbor and 
pair-wise distances and will be involved with all of the other calculations.  Another factor 
is the area enclosing the data set, or window.  For data on a cell, this window has the 
same dimensions as the cell.  Finally, when simulating data, the diameter of the domain 
populations will need to be considered.  With the exception of the last point, spatstat 
has built in functions for generating point patterns and the associated statistical analysis. 
Methods 
Defining domain locations 
 NanoSIMS data were processed using L'image, (L.R. Nittler, Carnegie Institution 
of Washington) a software package that runs in PV-Wave (Visual Numerics). Isotope 
enrichment ratio images, where the counts of the rare isotope ion was divided by the 
counts of the more abundant ion, and then divided by the natural abundance of the rare 
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isotope ((15N12C-/14N12C-)/0.00367), were analyzed with a particle definition algorithm 
(Figure 3.1d).  The location, size and ion intensities of these newly defined regions of 
interest were exported from L’image and used for further analysis (Figure 3.2a).  The 
intensity was smoothed over 3 by 3 pixels giving a lateral resolution of ≤176 nm. 
Whether the 19F- (hemagglutinin) counts exhibited statistically significant elevations in 
the 15N-sphingolipid domains was evaluated by comparing the average 19F- (per pixel) 
detected in the 15N-sphingolipid domains to that found in non-domain regions using a 
two-sample Kolmogorov-Smirnov test implemented with the MATLAB Statistics 
ToolboxTM.   
Analysis of sphingolipid domain organization  
 The spatial organization of the sphingolipid domains on the cell body was 
evaluated using spatstat (version 1.21-2) run in the R statistical programming 
environment (version 2.12.0).  A montage of the secondary electron images was loaded 
into GraphClick (version 3.0) and the scale was calibrated using three known points on 
the mosaic.   Points were placed along the cell body in the counter-clockwise direction 
so that a window could be created in R with the outputted coordinates.  This window is 
combined with the domain locations to make a planer point pattern, which is the input 
for the subsequent functions.   
 A variation of Ripley’s K function,9 known as the L function, was performed on 
the planer point pattern representing the locations of the sphingolipid domains.  The 
translation edge correction was employed to determine the organization of domains 
over all accessible length scales within the irregularly shaped cell window.  The data 
was normalized to the 99% confidence interval, determined by the formula: 
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99CI =1.68 A/N 
where A is the area of the cell window and N is the number of domains within the 
window.10  The normalized L test data minus the radius is plotted in Figure 3.2d.   
 To further determine the clustering behavior of the domains, the nearest neighbor 
distance was used to measure the distance from the center of a domain to the center of 
the closest domain.  This metric was compared with simulated data for the population of 
randomly positioned domains with the same distribution of domain diameters in the 
same cell window.  This data was binned in 250 nm increments and the difference 
between the observed and simulated data is plotted in Figure 3.2e.   
A more comprehensive metric is the pairwise distance between all domains 
within the cell window.  The domain pairwise distances were also compared to the 
simulated random data by binning the distances into 2 µm increments and taking the 
difference between the observed and simulated data, and are plotted in Figure 3.2f. 
Modification of simulation function  
A spatstat function that nearly accomplishes the desired simulation 
characteristics is rSSI.  This function allowed a single size of objects to be simulated.  It 
generates a randomly positioned point and then tests if the point is within the cell 
window, and if so, whether a minimum radius of separation exists between the new 
point an all other points in the marked point pattern.  This function continues until the 
specified number of points has been placed or space is not found for the remaining 
points.  Because this function does not keep track of the size of each object, only one 
size can be truly simulated.  This is a significant limitation; the domains on the cell 
sample have multiple sizes, so this function cannot accurately reproduce the possible 
 54 
domain configurations within the cell window.  To be realistic, these dimensions should 
be included when simulating their distributions. 
A function based on the rSSI function was written that incorporates marks to 
store the radius of each point, called rSSIM.  The following is the code for this function: 
rSSIM <- function(r,n,win=owin(c(0,1), c(0,1)), giveup = 10000, x.init = NULL) 
{ 
 stopifnot(is.numeric(r) && length(r)==1 && r >=0) 
 # quit if r is not a number, vector, negative or 0. 
 stopifnot(is.numeric(n) && length(n)==1 && n >=0) 
 # quit if n is not a number, vector, negative or 0. 
 win <- as.owin(win) 
 # make win a window (just in case it's not) 
 if (is.null(x.init)) 
  x.init <- ppp(x=numeric(0), y=numeric(0), window=win, marks=numeric(0)) 
 # initialize x.init to an empty marked ppp with window win 
 else stopifnot(is.ppp(x.init)) 
 # quit if x.init isn't a ppp  
 X <- x.init 
 r2 <- r^2 
 if(n*pi*r2/4 > area.owin(win))  
  stop(paste("Window is too small to fit",n,"points","at minimum separation",r)) 
 ntries <- 0 # initialize number of tries to 0; begin loop 
 while(ntries<giveup) { 
  ntries <- ntries + 1 # increment operation 
  qq <- runifpoint(1,win) # generate 1 random point in win 
  x <- qq$x[1] 
  y <- qq$y[1] # extract coordinates from random point just generated 
  marks(qq) <- r # mark the pattern with the radius 
  if(X$n==0 || all(((x-X$x)^2 + (y-X$y)^2) > (X$marks + r)^2)) 
  # check the distance between all points is greater than combined radii 
  X <- superimpose(X, qq, W = win) # merge the ppps into one 
  if(X$n == n) 
   return(X) # output the marked ppp 
  } # end loop 
 warning(paste("Gave up after",giveup, "attempts with only", X$n, "points out of",n)) 
 return(X) 
} 
This function is capable of simulating any number of randomly positioned objects, where 
each object consists of a point plus the surrounding area that is within the specified 
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radius (provided there is space), in any size and shape window such that the objects do 
not overlap (Figure 3.2b).   
Results and discussion  
 The ion and enrichment images are shown in Figure 3.1.  The secondary 
electron (Figure 3.1a) and 13C-enrichment (Figure 3.1c) mosaics were used to confirm 
the cell membrane remained intact and was free of areas with artificially high lipid 
signals.  Further analysis of the 19F- (Figure 3.1b) and 15N-enrichment (Figure 3.1d) 
mosaics, including the colocalization of these factors (Figure 3.2c) is discussed below. 
 
 
Figure 3.1 Mosaics of NanoSIMS ion and enrichment images.  (a) Secondary electron mosaic 
shows cell morphology.  (b) 19F- mosaic shows the location of influenza hemagglutinin.  (c) 13C-
enrichment mosaic indicates the total membrane lipids.  (d) 15N-enrichment mosaic shows the 
distribution of sphingolipids. 
 
 
An important spatial statistic is generated by Ripley’s L function, which evaluates 
the degree of object clustering, randomness, or order observed at each applicable 
length scale.  For L(r)-r, positive values indicate the objects are clustered; a value of 
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zero is characteristic of a randomly distributed population of objects, while negative 
values indicate non-randomly ordered objects.  The Ripley’s L function was used to 
evaluate the 15N-sphingolipid domain organization on the cell shown above.  The 
positive L(r)-r values shown in the plots in Figure 3.2d indicate the experimentally 
observed 15N-sphingolipid domains on the cell are clustered on all length scales greater 
than a few hundred nanometers, whereas the simulated domains are randomly 
positioned.   
The nearest neighbor profile can assess clustering on small length scales.  In 
Figure 3.2e the difference between the experimental and observed frequencies of 
nearest neighbor distances was the highest at a nearest neighbor distance of 500 nm.  
This indicates the experimentally observed domains on the cell surface are non-
randomly positioned such that their centers were about 500 nm from the center of the 
closest domain.  This profile suggests that the domains were positioned <200 nm from 
their nearest neighbor, as the average domain size is 350 nm. 
The final metric used to assess the domain organization is the pairwise distance, 
or the distance between the center of each domain and the center of every other 
domain on the cell.  The difference in frequencies of differences between the pairwise 
distances observed for the experimental and simulated domains is shown in Figure 3.2f.  
As in the nearest neighbor metric, the experimental domain population exhibits a 
greater frequency of distances below roughly 20 µm.  This may indicate a tendency for 
the domains to nonrandomly cluster within ≤20-µm-diameter regions on the cell. 
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Figure 3.2 Sphingolipid-enriched domain distribution on cell.  (a) Locations of domains detected 
with the particle definition algorithm (not to scale).  (b) Locations of simulated data, with radius 
of points varying with simulated particle size (not to scale).  (c) Colocalization image of 
hemagglutinin (red) and sphingolipids (green) and areas with colocalization (yellow) on the cell.  
(d) Plot of Ripley’s L-test, L(r) – r where r is the radial distance generated by the experimental 
and simulated data.  Data was normalized so the 99% confidence interval (CI 99%, red dashed 
line) is one.  The data for the experimental population of domains on the cell surface (blue) 
show clustering on all length scales greater than a few hundred nanometers, while data for the 
simulated population of randomly distributed domains (green) confirms their random distribution.  
(e) Plot of the difference in the frequency distribution of nearest neighbor distances measured 
for experimental domains and simulated randomly positioned domains.  (f) Plot of the difference 
in the frequency distribution of pairwise distances measured for the experimental domains and 
simulated randomly positioned domains. 
 
 
Whether the 15N-sphingolipid domains contain elevated levels of 19F- counts, and 
thus, the influenza virus membrane protein, hemagglutinin, was investigated using 
MATLAB.  A two-sample Kolmogorov-Smirnov test was used to examine if the 19F- 
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counts that identify hemagglutinin were elevated within sphingolipid domains.  At the 
95% confidence interval, the 19F- counts in sphingolipid domains were not statistically 
different from non-domain regions (h=0, p=0.26).  Similarly, the hypothesis that 19F- 
counts are higher in domain regions than in non-domain regions was rejected (h=0, 
p=0.13).  These results indicate that the hemagglutinin did was not preferentially located 
within the 15N-sphingolipid domains.  This conclusion was supported by visual 
examination of the 19F- and 15N-enrichment image mosaics, which showed about 20% of 
the 15N-sphingolipid domains were colocalized with the elevations in 19F- counts that 
locate the hemagglutinin.  In several other areas, the two locally elevated signals were 
within a few hundred nanometers of each other, but did not directly overlap.  Additional 
studies employing spatial statistic assessment with R are required to determine whether 
this represents non-random positioning of hemagglutinin clusters adjacent to 
sphingolipid domains.  
As mentioned in the introduction of this chapter, hemagglutinin clusters in 
electron dense domains that were thought to be composed of sphingolipids and 
cholesterol.6  The data shown here indicates that hemagglutinin and sphingolipids are 
not always within the same region of the cell membrane.  Thus, our data suggests the 
electron dense regions do not represent domains enriched with sphingolipids.  More 
samples should be assessed to confirm this result. 
Conclusion 
 The statistical methods for quantitative examination of NanoSIMS data have 
been developed.  Sphingolipid microdomain organization showed non-random 
clustering on multiple length scales.  The reason for this clustering is unknown, however, 
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this grouping of domains may play a role in cell function.  The comparison to randomly 
simulated data with the proper boundary conditions was helpful in determining whether 
the experimentally observed domains were randomly positioned on the cell surface.  
These statistical methods can be applied to many membrane species of interest and 
provide data for large portions of the cell membrane.  These large analysis areas not 
only provide an averaged look into local organization, but also provide information on 
longer length scales.   
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Chapter 4 
 
Identifying Differentiation Stage of Individual Primary Hematopoietic Cells from 
Mouse Bone Marrow by Multivariate Analysis of TOF-Secondary Ion Mass 
Spectrometry Data 
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Introduction 
The body’s full spectrum of blood and immune cells is generated from a small 
number of hematopoietic stem cells (HSCs) that are located within the bone marrow.2 
HSCs self-renew and differentiate into increasingly less-rare and more-mature HCs.3 
This renders HSCs of significant value for clinical treatment of hematopoietic 
pathologies and as models of stem cell differentiation.4  
Presently, much research focuses on developing culture systems that mimic the 
bone marrow’s chemotactic and micromechanical properties to enable control over HSC 
differentiation. Engineered biomaterials that exhibit spatial variations in mechanical 
properties and ligand presentation are especially attractive because they enable 
screening the effects of multiple microenvironments on HSC fate using a minimal 
number of cells.5 To utilize such combinatorial systems, rigorous methodologies to aid 
identification of HC differentiation stage at the single cell level with location specificity 
are highly attractive. Currently, differentiation stage is most commonly assessed via 
fluorescence microscopy using cocktails of differentiation stage specific antibodies;6 
however ambiguity from single-cell fluorescence analysis of small cell populations and 
inter-user variability of immunolabeling approaches can be a significant drawback.7  
We hypothesized that information about the expression profiles of cell surface 
antigens as well as other differences in cell surface chemistry could be acquired with 
time-of-flight secondary ion mass spectrometry (TOF-SIMS), and exploited to identify 
the differentiation stage of individual HCs within a culture. Mass spectral maps of the 
molecules at the surface of an individual cell can be collected with TOF-SIMS.8 
Because the spectra collected from biomaterials using TOF-SIMS instruments equipped 
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with liquid metal primary ion sources are dominated by low mass (m/z<300) fragment 
ions that are common to multiple biomolecules, multivariate analysis is often employed 
to discriminate the spectra of biomolecules and cells.8a, 9 Unknown samples have also 
been identified with supervised multivariate models that are constructed from the TOF-
SIMS data of known samples.9b, 9i For example, two different cell lines in a 
heterogeneous culture have been identified with location specificity by partial least-
squares discriminant analysis (PLS-DA) of TOF-SIMS data.10 Though this work 
achieved the location-specific identification required for studies of HSC fate decision, 
the accuracy of identifying primary cells that exhibit higher intra-population 
heterogeneity than laboratory cells lines11 with this approach has not been quantitatively 
assessed.  
Here, we report our efforts to classify individual primary murine HCs isolated from 
the bone marrow according to their stage in the B lymphocyte differentiation pathway by 
multivariate analysis of TOF-SIMS data. We focus on identifying three populations of 
primary HCs that were isolated from murine bone marrow via conventional flow 
cytometry (Figure 4.1): 1) hematopoietic stem and progenitor cells (HSPCs) that do not 
express lineage antigens (Lin-) but that do express Sca1 and cKit (Lin-Sca-1+c-Kit+, 
LSK); 2) common lymphoid progenitors (CLPs, Lin-IL-7Rα+Sca-1medc-Kitmed); and 3) 
mature B cells (B220+IgM+).3c, 12 These populations represent distinct cell phenotypes 
during lymphopoiesis: uncommitted stem and progenitor cells (HSPCs), lineage 
specified progenitor cells (CLPs), and fully-differentiated cells (B cells). We further 
investigated use of TOF-SIMS data to identify differences between HSPC populations 
isolated from young and old mice. Though isolated using identical sorting criteria, 
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significant age-related differences in HSC functionality have been previously reported, 
making classification approaches that do not rely on surface antigen expression 
especially significant.13 The potential for existence of populational subfractions with 
improved HSPC stemness, therefore, motivated study of whether TOF-SIMS 
approaches could segregate HSPCs isolated via identical flow conditions from young 
and old mice. 
 
Figure 4.1 Cellular constituents of HSC-mediated hematopoiesis. The blue, green, and red 
envelopes indicate the cell populations used in this study. The HSPC population (Lin-Scal+cKit+) 
used in our study (blue envelope) contains long-term HSCs (LT-HSCs) capable of sustained 
hematopoietic reconstitution, short-term HSCs (ST-HSCs) capable of limited hematopoietic 
constitution, and multipotent progenitors (MPPs) which retain lymphoid/myeloid lineage 
plasticity. B cell lymphopoiesis is marked by MPP progression to a common lymphoid progenitor 
(CLP, green envelope) cell capable of generating all T lymphocytes, B lymphocytes, dendritic 
cells (DC), and natural killer (NK) cells. B lymphopoieis further progresses through a sequence 
of defined precursor populations: pre-pro-B cell, pro-B cell, pre-B cell, immature-B cell (Im-B), 
and finally mature B cell (red envelope).3c Additional cell constituents depicted: CMP, common 
myeloid progenitor; MEP, megakaryotic/erythroid progenitor; GMP, granulocyte/monocyte 
progenitor. Image modified from Passegue et al.14 
 
Identification of the differentiation stage of individual primary HCs by multivariate 
analysis of TOF-SIMS data is complicated by the high degree of heterogeneity that 
exists within primary cell populations.15 Such intra-population heterogeneity can hinder 
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the detection of the differentiation-related spectral features.9a, 9d We selectively captured 
the spectral variation between, but not within, each cell population, by employing PLS-
DA models constructed using spectra from HCs of known differentiation status 
(calibration data set) to accurately identify the differentiation state of test HC cells. The 
lowest error of identification was achieved when the intra-population spectral variance 
that may be caused by auto-specific and age-related differences in cell surface 
chemistry were minimized. This approach may enable identifying cell differentiation 
status and its relationship to location within a colony or engineered microenvironment.  
Methods 
HC isolation and preparation  
The hematopoietic subpopulations were isolated from the femoral and tibial bone 
marrow of female C57BL/6 mice (Jackson Labs). Distinct age ranges were used for ‘old’ 
(10 months old) and ‘young’ (2 – 4 months old) mice. Euthanization and tissue collection 
were performed using IACUC approved methods. After isolation, the bones were gently 
crushed with a mortar and pestle, washed with a solution of phosphate buffered saline 
(PBS) + 2% fetal bovine serum (FBS) (PBS/FBS), and filtered with a 40 µm sterile filter 
to isolate whole bone marrow. All subsequent steps were then performed in a PBS/FBS 
solution on ice. Red blood cells were then lysed with ACK lysis buffer (Invitrogen, 
Carlsbad, CA) and re-suspended in PBS/FBS with Fc receptor-blocking antibody to 
reduce non-specific antibody binding. Aliquots of the mononuclear bone marrow cell 
population were then stained with distinct antibody cocktails to facilitate identification of 
the HSPC, CLP, and B cell populations using standardized sorting protocols.16 HSPCs 
(Lin- Sca-1+c-Kit+) were identified with a cocktail of antibodies: PE-conjugated Sca-1 
 66 
(1:100), APC-conjugated c-Kit (1:200), a FITC-conjugated Lineage (Lin) cocktail (CD5, 
B220, Mac-1, CD8a, Gr-1, Ter-119; 1:200), and a propidium iodide (PI) nuclear stain. 
CLPs (Lin-IL-7Rα+Sca-1medc-Kitmed) were identified with a cocktail of antibodies: PE-
conjugated Sca-1 (1:200), APC-conjugated c-Kit (1:200), PE-Cy 7-conjugated IL-7Rα 
(0.2 mg/mL), a fluorescein isothiocyanate- (FITC)-conjugated Lin cocktail (1:200), and a 
4',6-diamidino-2-phenylindole (DAPI) nuclear stain. Mature B cells (B220+IgM+) were 
isolated with a cocktail of antibodies: FITC-conjugated B220 (1:200), eFluor 450-
conjugated IgM (0.2 mg/mL), and a PI nuclear stain. All antibodies were supplied by 
eBioscience (San Diego, CA). Distinct HSPC, CLP, and B-cell populations were then 
isolated using a BD FACS Aria II flow cytometer operated by the BD FACS Diva 
software.  FACS plots for HSPCs, CLPs, and B-cells showed populations consistent 
with previous results in the literature.3c, d, 16-17  Cells were collected on polylysine-coated 
substrates on ice and were then chemically fixed in 4% glutaraldehyde diluted with PBS 
within 4 hr after collection, followed by osmication in 0.4% osmium tetroxide diluted with 
triple-distilled water and filtered using a 0.22 µm syringe filter directly prior to use. Cells 
were rinsed for 20 min in triple distilled water and allowed to air dry. To facilitate locating 
the cells in the TOF-SIMS, optical maps of each sample substrate were created with an 
optical microscope (Leica DM6000 B, Q-Imaging EXi Blue Fluorescence Microscope) 
that was operated in reflectance mode. 
TOF-SIMS  
Mass spectral images were acquired in unbunched mode (total primary ion dose 
= 3 x 1013 ions/cm2) using a PHI Trift-III TOF-SIMS (Physical Electronics Incorporated, 
Chanhassen, MN) instrument with a 197Au+ liquid ion gun that was operated at 22 kV. 
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The primary ion beam was raster scanned across the sample, and positive-ion spectra 
with a mass range of 0 to 800 amu were acquired at each pixel.  
Data analysis  
Multivariate analysis was performed using the PLS Toolbox (v.6.2.1, Eigenvector 
Research, Manson, WA) run in MATLAB (v.7.12.0 R2011a, MathWorks Inc., Natick, 
MA). Unit mass binned spectra of individual cells were extracted from the TOF-SIMS 
images and imported into the PLS toolbox. Outlier spectra that exhibit unusual variation 
were identified as described below and Figure 4.2, and excluded from further analysis.  
 
Figure 4.2 Identification of outlier spectra from cells harvested from the old (A) and young (B) 
mice. Using the spectra acquired for each group of cells, a PC model with two principal 
components was constructed using the mass peaks in the 1 – 300 m/z range.  Outlier samples 
exhibited spectral variation that was not captured by the PCA model.  The outlier spectra 
(indicated with black arrows) have Q residual values that are greater than the 95% confidence 
interval (horizontal dashed line).  These samples were removed from the data set and excluded 
from further analysis. 
 
Spectra that exhibit unusual variation that might be caused by sample 
contamination or high levels of inorganic ions that alter the relative intensity of the other 
mass peaks in the spectra can compromise the predicative ability of a multivariate 
model.6-7 To detect the spectra that exhibited unusual variance compared to the rest of 
the cells that were harvested from the same set of mice, PCA was performed on the 
mass peaks between 1 and 300 m/z in the spectra. The upper mass of 300 m/z was 
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selected because peaks with m/z > 300 have poor detection reproducibility using our 
instrumentation.8 Each mass peak was normalized to the total intensity of the peaks in 
the spectrum and autoscaled to the spectra in the data set. Two separate PCA models 
with two principal components (PCs) were constructed: one for the cell spectra from the 
old mice, and another for the cell spectra from the young mice. The plot of the Hotelling 
T2 statistic versus the Q residual contributions (Figure 4.2) was used to identify the 
samples that had a Q statistic greater than the 95% confidence limit, which indicates the 
sample exhibited unusual variance that was not captured by the model. For the data set 
consisting of the cells harvested from the five old mice, the spectra from 6 HSPCs, 5 
CLPs, and 1 B cell (arrows, Figure 4.2A) were identified as outliers. Spectra from 3 
HSPCs, 2 CLPs, and 1 B cell (arrows, Figure 4.2B) that were harvested from the group 
of young mice were identified as outliers and excluded from further analysis. These 
outlier spectra were excluded from further analysis. 
PLS-DA Model Construction  
PLS-DA was performed on the peaks in the m/z 50 to 300 range. This range was 
selected because ions with m/z < 50 are not chemically specific8a and peaks with m/z > 
300 have poor detection reproducibility using our instrumentation.9e Two different peak 
sets were employed to analyze the HC spectra: 1) a cell-related peak set consisting of 
the mass peaks that are known to be produced by phosphocholine, fatty acids, and 
amino acids9d but not common surface contaminants (m/z 73, 133, 147, 207, 221, and 
281)18 (Table 1); and 2) a complete peak set that consisted of all mass peaks from m/z 
50 to 300 except those related to the aforementioned contaminants. Previous studies 
indicated that the cell-related peak set is applicable to chemically fixed biological 
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samples.9d, 19 Each peak was normalized to the total intensity of the remaining peaks in 
the spectrum and autoscaled to the data set. The PLS-DA model was constructed using 
the minimum number of latent variables (LVs) required to capture at least 80% of the 
variance in the test spectra. Identification plots were generated to determine which cells 
exceed the classification threshold for the indicated class, where the classification 
threshold was estimated using Bayes’ Theorem.20 Variable importance in projection 
(VIP) score plots that show the magnitude that each mass peak contributes to 
identifying the indicated cell population were also generated.  Figure 4.3 details the 
construction of specific PLS-DA models.  
Table 4.1 List of the mass peaks in the cell-specific peak set and the biomolecules that are 
related to these peaks.9d,8a  Peaks that are produced by common surface contaminants were 
omitted.18    
Mass 
(m/z) Related Biomolecule 
51 phenylalanine 
53 lipid (C4H5+) 
54 lipid fragment (13C12C3H5+) 
55 lipid fragment (C4H7+), arginine, lysine, cysteine, valine, leucine, histidine 
56 lipid fragment (C3H6N
+), lysine, methionine, glutamine, asparagine, 
threonine, isoleucine 
57 lipid fragment (C4H9
+), valine, serine, alanine, arginine, cysteine, aspartic 
acid, leucine, threonine, glycine 
58 lipid fragment (C3H8N+), isoleucine 
59 lipid fragment (13C12C2H8N+), arginine, valine 
60 lipid fragment (C3H10N+), serine 
61 methionine 
67 lipid fragment (C5H7+) 
68 lipid fragment (C4H6N+), proline 
69 lipid fragment (C5H9+), isoleucine, histidine, lysine 
70 lipid fragment (C4H8N
+), proline, leucine, glutamic acid, asparagine, 
arginine 
71 lipid fragment (C5H11+) 
72 lipid fragment (C4H10N+), valine 
74 lipid fragment (C4H12N+) threonine 
76 cysteine, glycine 
77 phenylalanine 
81 lipid fragment (C6H9+), alanine 
82 lipid fragment (C5H8N+), histidine 
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83 lipid fragment (C6H11+) 
84 lipid fragment (C5H10N+), lysine, glutamine, glutamic acid 
85 lipid fragment (C6H13+) 
86 lipid fragment (C5H12N+), isoleucine, leucine 
87 asparagine 
88 lipid fragment (C5H14N+), aspartic acid 
90 alanine 
91 lipid fragment (C7H7+), serine, phenylalanine, methionine 
93 lipid fragment (C7H9+) 
95 lipid fragment (C7H11+), histidine 
97 lipid fragment (C7H13+) 
98 lipid fragment (C5H8NO+), glycine 
100 lipid fragment (C5H10NO+) 
101 glutamine 
102 lipid fragment (C5H12NO+), glutamic acid 
103 phenylalanine 
104 lipid fragment (C5H14NO+), lysine 
106 serine 
107 tyrosine 
110 histidine 
111 lipid fragment (C8H15+) 
112 alanine 
116 serine, tyrosine, threonine, proline 
117 tryptophan, proline 
118 valine 
120 phenylalanine, methionine, threonine, glycine 
122 cysteine 
123 tyrosine 
128 serine 
130 glutamine, tryptophan, glutamic acid 
132 isoleucine, leucine 
133 asparagine 
134 alanine, aspartic acid 
136 tyrosine 
138 proline 
143 tryptophan 
146 lipid fragment (C5H9NPO2+) 
148 lipid fragment (C5H11NPO2+), glutamic acid 
150 lipid fragment (C5H13NPO2+), methionine 
155 asparagine, aspartic acid 
156 histidine 
159 tryptophan 
165 tyrosine 
166 lipid fragment (C5H13NPO3+), methionine, phenylalanine 
168 lipid fragment (C5H15NPO3+) 
175 arginine, glutamic acid 
177 asparagine 
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178 glycine 
179 alanine 
182 lipid fragment (C5H13NPO4+), tyrosine 
184 lipid fragment (C5H15NPO4+) 
188 tryptophan 
190 lipid fragment (C7H13NPO3+) 
194 lipid fragment (C7H17NPO3+) 
196 lipid fragment (C6H15NPO4+) 
198 lipid fragment (C6H17NPO4+) 
200 glycine 
205 tryptophan 
206 lipid fragment (C5H14NPO4Na+) 
210 lipid fragment (C7H17NPO4+) 
212 lipid fragment (C7H19NPO4+) 
219 aspartic acid, cysteine 
224 lipid fragment (C7H15NPO5+) 
226 lipid fragment (C7H17NPO5+) 
231 proline 
235 valine 
238 lipid fragment (C8H17NPO5+) 
239 threonine 
240 lipid fragment (C8H19NPO5+) 
241 cysteine 
246 lipid fragment (C8H18NPO4Na+ or C8H18NPO5Li+) 
252 lipid fragment (C8H15NPO6+) 
254 lipid fragment (C8H17NPO6+) 
256 lipid fragment (C8H19NPO6+) 
263 isoleucine, leucine 
279 aspartic acid, glutamine 
282 lipid fragment (C9H17NPO7+) 
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Figure 4.3 Plots show the contributions of the peaks in the cell-related peak set to the overall Q 
residual and Hotelling’s T2 statistic in the preliminary PLS-DA models. Peaks with high Q 
residual contributions and low Hotelling’s T2 contributions vary in a manner that is not related to 
HC differentiation status. (A) The preliminary PLS-DA model that was used to test the 
differentiation status of cells that were harvested from the same aged mice as the calibration set 
was refined by excluding the mass peaks with Q contributions above 30% (red). (B) The 
preliminary PLS-DA model that was used to test the differentiation status of cells that were 
harvested from young mice was refined by excluding the mass peaks with Q contributions 
above 60% (red). 
 
PLS-DA Model for Identification of the Differentiation Stage of Hematopoietic 
Cells Isolated from the Same Mice  
After removing the outlier spectra, the remaining normalized spectra in the old 
mice data set were divided into two sets that were nearly equal in size: an old mice 
calibration set consisting of 15, 13, and 15 randomly selected B cells, CLPs, and 
HSPCs, and an old mice test set consisting of spectra from the remaining 15, 12, and 
13 B cells, CLPs, and HSPCs.  Using the cell-related peak set, a preliminary PLS-DA 
model was constructed and refined by excluding the mass peaks with Q contributions 
above 30% (m/z 90, 98, 102, 110, 111, 120, 122, 188, 196, and 200) (Figure 4.3A).  
The peaks with these high Q residual contributions had intensities that varied 
significantly between cells but were not indicative of differentiation status.  Using the 
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remaining spectra, a PLS-DA model was constructed that consisted of five LVs that 
captured 61.2% of the variance in the calibration data, and 81.4% of the variance in the 
test spectra.  The PLS-DA model was then used to predict the differentiation status of 
the cells in the test set.  When this process was repeated using the complete peak set 
described above, a PLS-DA model with 4 LVs that captured 43.1% and 83.4% of the 
variance in the calibration and test spectra, respectively, was constructed and used to 
predict the differentiation status of the cells in the test set.   
Preparation of Samples of Population-Specific Antibody Cocktails  
A separate sample was prepared for each aforementioned antibody cocktail used 
to isolate the HC populations.  A 20 µL droplet of the antibody cocktail was spotted onto 
a 5 x 5 mm silicon substrate and allowed to air dry.  The samples were chemically fixed 
as described above, but osmuim tetroxide treatment was omitted. The omission of 
osmium tetroxide is not expected to affect which peaks contribute significantly to 
identifying each antibody cocktail because because osmuim tetroxide does not react 
with proteins,21 and only affects the intensity of the peaks that contain phosphate 
moieties does not produce new peaks in positive ion spectra over the m/z 1 – 300 range.  
PLS-DA Model of Spectra from HC Population-Specific Antibody Cocktails  
PLS-DA of the spectra acquired from the population-specific antibody cocktail 
samples was performed using the same peaks and preprocessing conditions as those 
used to construct the model shown in Figure 4.4. The calibration set consisted of 15 
spectra of the B cell-specific antibody cocktail, 15 spectra of the CLP-specific antibody 
cocktail, and 14 spectra of the HSPC-specific antibody cocktail.  The resulting PLS-DA 
model consisted of two LVs that captured 81.3% of the variance in the test set.      
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Figure 4.4 Identification plots and VIP score plots for the PLS-DA models constructed using the 
cell-related peaks in the calibration spectra of HCs that were harvested from the same mice as 
the cells in the test set. The cells that exceeded the classification threshold (red dashed line) in 
the prediction plots were identified as (A) B cells, (B) CLPs, and (C) HSPCs. The VIP score 
plots for this model show the importance of each mass peak towards the identification of the (D) 
B cells, (E) CLPs, and (F) HSPCs. Peaks with VIP scores greater than unity are important for 
identifying the indicated population. 
 
 
Construction of Principal Component Analysis (PCA) Models of each HC 
Population  
Each spectrum was filtered so that it consisted of only the cell-related peaks 
within the m/z 50 to 300 range, and each peak was normalized to the total intensity of 
the remaining peaks in the spectrum. A data set consisting of the spectra of cells that 
were harvested from the old and young mice was created for each HC population. Each 
peak in the data set was autoscaled, and a separate PCA model was constructed for 
the B cells, CLPs, and HSPCs. The PCA model contained the minimum number of PCs 
that were required to separate the cells harvested from the young and old mice. Scores 
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plots that show the projection of each sample onto the PCs and loading plots that show 
the contribution of each peak to each PC were generated.  
Results 
The Differentiation Status of Primary HCs Isolated from Mouse Bone Marrow Can 
Be Identified by PLS-DA of TOF-SIMS Data 
A PLS-DA model was constructed from a calibration data set consisting of the 
spectra acquired from 15 B cells, 13 CLPs, and 15 HSPCs isolated from five old mice. 
This PLS-DA model was then used to identify the differentiation stage of 15 B cells, 12 
CLPs, and 15 HSPCs (test data set) also harvested from the same mice. To increase 
the probability that the identification was based on cell surface biomolecules and not 
contaminants, only the peaks that were related to amino acids, phosphocholine, and 
fatty acids were analyzed (cell-related peak set, Table 4.1.9d, 18 Figure 4.4A - 4.4C 
shows the identifications made with the PLS-DA model, where the cells that exceeded 
the classification threshold (red dashed lines in Figure 4.4A - 4.4C) were identified as 
the indicated population. Table 4.2 lists the sensitivity (the fraction of cells in the 
specified population correctly identified as that population), specificity (the fraction of 
cells from other populations that were correctly identified as not in the specified 
population) and error (average of the false positive and false negative rates) for 
identifying each HC population. The differentiation stages of the calibration cells were 
re-identified with high sensitivity and specificity, and the errors for identifying the B cells, 
CLPs, and HSPCs in the calibration set were only 0%, 2%, and 10%, respectively. 
Likewise, the differentiation stages of the cells in the test set were also identified with 
high sensitivity, high selectivity, and low error (3%, 8%, and 11% identification error for 
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the test B cells, CLPs, and HSPCs, respectively). Thus, the variance in the peaks 
related to amino acids, phosphocholine, and fatty acids in the spectra was characteristic 
of HC populations, and could be exploited to identify the differentiation stage of 
individual HCs. 
Table 4.2 The sensitivity, specificity, and class error of differentiation stage identification made 
with the PLS-DA model constructed using the cell-specific peak set and the complete peak set. 
 Cell-Specific Peak Set Complete Peak Set 
 B Cells CLPs HSPCs B Cells CLPs HSPCs 
Sensitivity of Identification of 
Calibration Samples 
1.0 1.0 0.87 1.0 0.92 1.0 
Specificity of Identification of 
Calibration Samples 
1.0 0.97 0.93 1.0 1.0 0.85 
Sensitivity of Identification of 
Test Samples  
0.93 0.83 1.0 1.0 0.92 1.0 
Specificity of Identification of 
Test Samples 
1.0 1.0 0.78 1.0 1.0 0.85 
Class Error of Identification of 
Calibration Samples 
0 0.02 0.10 0 0 0.02 
Class Error of Identification of 
Test Samples 
0.03 0.08 0.11 0 0.04 0.07 
 
The contributions of each mass peak to the spectral variance that identifies the B 
cells, CLPs, and HSPCs are shown in the variable importance in projection (VIP) plots 
(Figure 4.4D – 4.4F). Peaks with VIP scores greater than unity exhibit variance that is 
important towards identifying the indicated population.22 For at least two of the three cell 
types, peaks m/z 53, 55, 86, 130, 148, 166, 184, 190, 205, 206, 210, and 279 have high 
VIP scores. Although some of these peaks are related to multiple biomolecular building 
blocks, phosphocholine, fatty acids, glutamine, glutamic acid, leucine, and tryptophan 
are likely candidates for the parent components because they are related to two or more 
of the peaks with high VIP scores. The amino acid-related peaks with high VIP scores 
might reflect changes in the differentiation-specific proteins expressed on the cell 
surface, or the presence of the different antibodies used to isolate each HC population 
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by flow cytometry. To investigate whether the antibodies used for cell isolation 
significantly contributed to cell identification, a PLS-DA model was constructed using 
spectra from the antibody cocktails that were used to isolate each HC population.  Few 
of the peaks with the highest importance towards identifying the B cells, CLPs, and 
HSPCs (Figure 4.4D – 4.4F) also had high importance towards identifying the 
antibodies used to isolate the B cells, CLPs, and HSPCs (Figure 4.5A – 4.5C), 
respectively.  This suggests that the mass fragments produced by the population-
specific antibodies did not contribute significantly to the spectral variation that identified 
each HC population.  Though analysis of only the peaks related to amino acids, 
phosphocholine, and fatty acids increases the probability that the identifications are 
based on biomolecules and not sample-specific contaminants, it precludes detecting 
differentiation-related variations in other cell surface components, such as glycans.23 
Higher sensitivity and specificity of identifying the calibration and test cells was achieved 
when PLS-DA was performed using all of the peaks between 50 and 300 m/z that were 
not related to known contaminants (Table 4.2 and Figure 4.6). However, the resulting 
model may not be applicable towards identifying the differentiation stage of other cell 
samples if the peaks with high VIP scores were related to sample-specific 
contaminants, and not cell biomolecules.  
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Figure 4.5 The VIP score plots show the importance of each mass peak towards the 
identification of the (A) B cell-specific antibodies, (B) CLP-specific antibodies, and (C) HSPC-
specific antibodies that were used to isolate each cell population using flow cytometry. 
 
 
 
Figure 4.6 The (A) B cell, (B) CLP, and (C) HSPC identification plots for the PLS-DA model 
constructed using the complete peak set show the cells that exceed the threshold  (red dashed 
line) for identification as the indicated cell type. The VIP plots for the (D) B cells, (E) CLPs, and 
(F) HSPCs show that many peaks from unknown sources were important towards identifying the 
indicated population (purple peaks). 
 
Extent of Intra-Population Variation between HCs from Mice that Differ in Age 
This approach to identifying HC differentiation status would have greater 
applicability if the PLS-DA model could be constructed using the spectra of cells that 
were harvested from different mice as those in the test set. However, primary cells from 
different mice exhibit auto-specific and age-related differences in cell surface 
chemistry.11, 13a Though subtle, these differences may increase the intra-population 
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spectral variance between the calibration and test cells to a level that is detrimental to 
identifying cell differentiation stage. To investigate whether such changes in cell surface 
chemistry induce detectable spectral variance within each HC population, PCA was 
performed on the spectra of cells that were harvested from two sets of C57BL/6 mice 
that differed in age: 10-month-old (old) and 2- to 4-month-old (young) mice. These two 
age groups were selected because HSCs from mice of these ages exhibit identical 
surface antigen expression but significant functional and epigenetic differences.13 Note 
that the intra-population spectral variation detected between these old and young cells 
is likely larger than that exhibited by the cells that are used to study HSC fate decisions 
(typically < 6 months of age).15b, 24  
The B cells from the old and young mice were not separated on the first principal 
component (PC) of the PCA model (Figure 4.7). This indicates the linear combination of 
mass peaks whose intensities varied the most (26%) within this B cell population was 
not caused by auto-specific or age-related changes in cell chemistry. However, the B 
cell spectra from the young and old mice were separated on PC2 and PC3; the young B 
cells had positive scores on PC2 and PC3, whereas the old B cells had negative scores 
on PC2 and/or PC3 (Figure 4.8A). The majority of the peaks with high negative 
loadings on both PC2 and PC3, and therefore, higher normalized intensities in the 
spectra of the B cells from the old mice, were mainly related to lipids (m/z 86, 166, 168, 
182, 184, and 224). In contrast, many of the peaks with high positive loadings on PC2 
and PC3, and higher normalized intensities in the spectra of B cells from the young 
mice, were related to amino acids (m/z 51, 130, 155, 178, 179, 205, 263, and 279). This 
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suggests that the B cells from the young mice had a higher ratio of proteins to lipids on 
their surfaces than the B cells from the old mice.  
 
Figure 4.7 (A) PC score plot shows that PC1 captured the largest percentage of spectral 
variation in the B cell spectra, but did not separate the B cell spectra according to the age of the 
mice that the cells were harvested from.  The elliptical region that is outlined with the dashed 
blue line represents the 95% confidence limit of the PC model. (B) The loadings plot shows the 
contribution of each peak to the variation captured by each PC. 
 
 
 
 
Figure 4.8 PC score and loadings plots were constructed using the spectra from the B cells (A), 
CLPs (B), and HSPCs (C) that were harvested from the old and young mice. The region within 
the dashed blue line on each score plot represents the border for the 95% confidence limit of 
the entire PC model. The loading plots for each cell type show the extent that each mass peak 
contributed to the variance captured by the indicated PC. 
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For the PCA models constructed for the CLPs and HSPCs, the first PCs captured 
approximately half of the spectral variance in the data set and separated the spectra of 
cells from the old and young mice (Figure 4.8B – 4.8C). Thus, the major source of 
spectral variation in the HSPC and CLP populations could be attributed to age-related 
and auto-specific differences in cell surface chemistry. In both models, the CLPs and 
HSPCs from the young mice had positive scores on PC1 and PC2, whereas the CLPs 
and HSPCs from the old mice had negative scores on PC1 and/or PC2. The peaks with 
high negative loadings on PC1 and PC2 were mainly related to lipids, whereas peaks 
that were mainly related to amino acids had high positive loadings on these two PCs 
(Figure 4.8B – 4.8C). Thus, like the B cells, the surfaces of the CLPs and HSPCs from 
the old mice have lower protein to lipid ratios than the surfaces of the CLPs and HSPCs 
from the young mice. 
Though a more extensive study that employs a larger number of mice would be 
required to confirm these results, this preliminary data suggests that all three HC 
populations exhibit an age-related decrease in the protein to lipid ratio on the cell 
surface.  This finding is consistent with previous work that demonstrated glycerolipid 
metabolism increases in the tissues of aged mice.25 However, complementary metabolic 
profiling analyses would be required to exclude the possibility that age-related increases 
in protein misfolding lead to an increase in the degradation or intracellular accumulation 
of protein,26 and a decrease in the protein to lipid ratio on the aged HCs. 
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Effects of Intra-Population Variation between the Calibration and Test Spectra on 
the Identification of HC Differentiation Stage 
We next assessed whether the intra-population spectral variance detected with 
PCA was significant enough to compromise the identification of HC differentiation stage. 
The spectra of 30 B cells, 25 CLPs, and 29 HSPCs that were harvested from the old 
mice were used to construct a PLS-DA model that was used to identify the 
differentiation stage of the 20 B cells, 20 CLPs, and 14 HSPCs in the test data set from 
the young mice. Self-identification of the old B cells, CLPs, and HSPCs in the calibration 
set was achieved with ≤4% error (Figure 4.9A – 4.9C, Table 4.3), demonstrating the 
variance between the calibration cells was well-captured by the model. The peaks with 
high VIP scores (Figure 4.9D – 4.9F) were similar to those in Figure 4.4D – 4.4F. 
Identification of the differentiation stage of the test HCs from the young mice using this 
model was less accurate, as the errors for identifying the test B cells, CLPs, and HSPCs 
from the young mice were 19%, 26% and 11%, respectively (Table 4.3). Thus, auto-
specific and age-related differences in the calibration and test spectra appeared to 
compromise the identification of HC differentiation stage. 
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Figure 4.9 The differentiation stages of HCs harvested from young mice were identified using a 
PLS-DA model that was created using the cell-related peaks in a calibration set of spectra from 
HCs harvested from old mice. The cells that exceeded the threshold (red dashed line) were 
identified as (A) B cells, (B) CLPs, and (C) HSPCs. The VIP score plots show the importance of 
each mass peak towards the identification of the (D) B cells, (E) CLPs, and (F) HSPCs. 
 
Table 4.3 The sensitivity, specificity, and class error of identification of the differentiation stage 
of HCs harvested from old (calibration set) and young (test set) mice determined for the PLS-DA 
models constructed using the cell-specific peak set and the complete peak set.  
 Cell-Specific Peak Set Complete Peak Set 
 B Cells CLPs HSPCs B Cells CLPs HSPCs 
Sensitivity of Identification 
of Calibration Samples 
1.0 1.0 0.97 0.93 1.0 0.93 
Specificity of Identification 
of Calibration Samples 
0.98 0.97 0.96 0.96 0.98 0.95 
Sensitivity of Identification 
of Test Samples  
0.65 0.95 0.86 0.35 1.0 0.14 
Specificity of Identification 
of Test Samples 
0.97 0.53 0.93 0.97 0.47 0.88 
Class Error of Identification 
of Calibration Samples 
0.01 0.02 0.04 0.05 0.01 0.06 
Class Error of Identification 
of Test Samples 
0.19 0.26 0.11 0.34 0.26 0.49 
 
Finally, we investigated whether use of the complete peak set improved the 
precision of identifying HC differentiation stage. The errors in identifying the calibration 
cells were ≤6% (Table 4.3), respectively, which is similar to that achieved with the cell-
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related PLS-DA model. Inclusion of the mass peaks that were related to unknown 
biomolecules in the analysis was detrimental to identifying the differentiation status of 
the test cells from the young mice; the prediction error rose to 34%, 26%, and 49% for 
the test B cells, CLPs, and HSPCs, respectively (Table 4.3, Figure 4.10). Thus, the 
peaks not related to amino acids, phosphocholine, or fatty acids varied significantly 
between the spectra in the calibration and test sets. Additional work towards identifying 
the parent molecules that produced the unknown peaks with high VIP scores is required 
to determine whether the spectral variation between the calibration and test cells was 
due to contaminant molecules or changes in cell surface chemistry.   
 
Figure 4.10 The (G) B cell, (H) CLP, and (I) HSPC identification plots for the PLS-DA model 
that was constructed using the complete peak set show that the inclusion of the peaks from 
unknown sources was detrimental to identifying each cell population. The VIP plots for the (J) B 
cells, (K) CLPs, and (L) HSPCs shows that many of the peaks that were important towards 
identifying the cells in each population were not included in the cell-related peak set (purple 
peaks). The parent molecules that produced these fragments are not known. 
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Discussion and Conclusion 
Biomaterial substrates that exhibit orthogonal gradients in composition and 
stiffness have the potential to permit elucidation of the combination of cues that induce 
specific HSC fates.  The rarity of these cells in the body makes quantitative single cell 
analysis methods particularly valuable.    To realize this potential, robust methods must 
be developed to identify the differentiation stages of individual HSCs at distinct regions 
on a biomaterial.  For this purpose, we have shown that TOF-SIMS data encodes for 
the surface chemistries exhibited by distinct HC populations, and PLS-DA can translate 
this chemical data into HC differentiation stage. Because PLS-DA uses numerical 
algorithms to quantify the probability that a HC is at the specified differentiation stage, 
this approach is more objective and less prone to inter-user variability than traditional 
immunolabeling methods. Additionally, cell surface chemistries that may be distinctive 
of individual organisms or aging are also encrypted in the TOF-SIMS data. Differences 
between the auto-specific and age-related surface chemistries exhibited by the cells in 
the calibration and test sets induce spectral variance that compromises the identification 
of HC differentiation stage. Consequently, the cells employed to construct the PLS-DA 
model should be from the same age group as the unknown cells in the test set to 
optimize precision.  
Having demonstrated the feasibility of identifying the differentiation stages of 
individual primary HCs with location specificity by multivariate analysis of TOF-SIMS 
data, we expect ongoing work may enable the identification of additional HC 
subpopulations.  To improve our capacity to detect subtle changes in HC phenotype, we 
are currently incorporating additional distinct HC subpopulations to construct a next 
 86 
generation of PLS-DA models. Most significantly, the HSPC population used in the 
current analyses contains a mix of stem and progenitor cells with differential long-term 
stem cell potential (Figure 4.1). Future work that examines significantly more rare 
hematopoietic subpopulations (i.e. LSK CD150+CD244-CD48-)7 that are specifically 
enriched for the most primitive HSCs subpopulations and show significant age-related 
changes in stemness24d would likely enhance our ability to identify early HSC fate 
decisions.  Overall, we expect that use of this approach to identify the differentiation 
stages of individual HCs within combinatorial biomaterials will greatly facilitate 
correlating HSC fate decisions to environmental cues, critical to the design of ex vivo 
culture systems in order to control HSC bioactivity. 
Our data indicate that the ratio of proteins to lipids on the surfaces of B cells, 
CLPs, and HSPCs decreases as the age of the donor mouse increases.  Though we 
limited discussion of this observation to comparison with current knowledge in the field, 
this finding demonstrates that information on the cell surface chemistries that differ 
between HC populations may be acquired with this approach.  Presently, the amount of 
compositional information that can be extracted from the data presented herein is 
restricted by two factors; our ability to ascertain the origins of the peaks with high 
importance towards identifying each HC population, and the quality of the mass spectra.  
Published databases of TOF-SIMS peaks that are related to lipids,9d amino acids,8a, 9k 
and nucleobases27 facilitate interpreting TOF-SIMS data.  Identification of the mass 
peaks associated with glycans, cholesterol, and other cell surface molecules would also 
aid this effort.  The low mass range that could be detected with our instrumentation and 
use of unit mass binning, which reduced the mass resolution such that multiple 
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molecules likely contributed to each spectral peak, ultimately limit the compositional 
information that might be extricated from our data.  Use of a TOF-SIMS instrument with 
a cluster ion source that enhances the yields of high mass ions28 and a mass 
spectrometer with higher mass resolving power and sensitivity would greatly enhance 
interpreting the population-specific spectral variance and identifying HC differentiation 
stage. Alternatively, a MALDI-TOF with sufficient spatial resolution to analyze individual 
cells may enable the more sensitive acquisition of mass spectra with a wider mass 
range and higher mass resolution from individual HCs. We expect that with the 
aforementioned improvements in technology and databases, multivariate analysis of 
TOF-SIMS data may also enhance efforts to elucidate the biomolecular changes that 
occur during differentiation or accompany age-related deficits in HC function. 
  
 88 
References 
1. Frisz, J. F.; Choi, J. S.; Wilson, R. L.; Harley, B. A. C.; Kraft, M. L., Identifying 
Differentiation Stage of Individual Primary Hematopoietic Cells from Mouse Bone 
Marrow by Multivariate Analysis of TOF-Secondary Ion Mass Spectrometry Data. 
Analytical Chemistry 2012, 84 (10), 4307-4313. 
2. (a) Weissman, I. L., Stem Cells: Units of Development, Units of Regeneration, 
and Units in Evolution. Cell 2000, 100 (1), 157-168; (b) Frankel, D.; Pfeiffer, J.; 
Surviladze, Z.; Johnson, A.; Oliver, J.; Wilson, B.; Burns, A., Revealing the topography 
of cellular membrane domains by combined atomic force microscopy/fluorescence 
imaging. In Biophysical journal, 2006; Vol. 90, pp 2404-2413; (c) Yin, T.; Li, L., The 
stem cell niche in bone. J. Clin. Invest. 2006, 116 (5), 1195-1201; (d) Calvi, L. M.; 
Adams, G. B.; Weibrecht, K. W.; Weber, J. M.; Olson, D. P.; Knight, M. C.; Martin, R. P.; 
Schipani, E.; Divieti, P.; Bringhurst, F. R.; Milner, L. A.; Kronenberg, H. M.; Scadden, D. 
T., Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425 
(6960), 841-846. 
3. (a) Wilson, A.; Trumpp, A., Bone-marrow haematopoietic-stem-cell niches. 
Nature Rev. Immunol. 2006, 6 (2), 93-106; (b) Cariappa, A.; Pillai, S., Antigen-
dependent B-cell development. Curr Opin Immunol 2002, 14 (2), 241-9; (c) Hardy, R. 
R.; Hayakawa, K., B Cell Development Pathways. Annu. Rev. Immunol. 2001, 19 (1), 
595-621; (d) Yang, L.; Bryder, D.; Adolfsson, J.; Nygren, J.; Mansson, R.; Sigvardsson, 
M.; Jacobsen, S. E., Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term 
hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated 
transplant recipients. Blood 2005, 105 (7), 2717-23; (e) Adolfsson, J.; Borge, O. J.; 
Bryder, D.; Theilgaard-Monch, K.; Astrand-Grundstrom, I.; Sitnicka, E.; Sasaki, Y.; 
Jacobsen, S. E., Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-
kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 
2001, 15 (4), 659-69; (f) Adolfsson, J.; Mansson, R.; Buza-Vidas, N.; Hultquist, A.; 
Liuba, K.; Jensen, C. T.; Bryder, D.; Yang, L.; Borge, O. J.; Thoren, L. A.; Anderson, K.; 
Sitnicka, E.; Sasaki, Y.; Sigvardsson, M.; Jacobsen, S. E., Identification of Flt3+ lympho-
myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for 
adult blood lineage commitment. Cell 2005, 121 (2), 295-306. 
4. Daley, G. Q.; Scadden, D. T., Prospects for stem cell-based therapy. Cell 2008, 
132 (4), 544-8. 
5. (a) Martin, T. A.; Caliari, S. R.; Williford, P. D.; Harley, B. A.; Bailey, R. C., The 
generation of biomolecular patterns in highly porous collagen-GAG scaffolds using 
direct photolithography. Biomaterials 2011, 32 (16), 3949-3957; (b) Mei, Y.; Saha, K.; 
Bogatyrev, S. R.; Yang, J.; Hook, A. L.; Kalcioglu, Z. I.; Cho, S.-W.; Mitalipova, M.; 
Pyzocha, N.; Rojas, F.; Van Vliet, K. J.; Davies, M. C.; Alexander, M. R.; Langer, R.; 
Jaenisch, R.; Anderson, D. G., Combinatorial development of biomaterials for clonal 
growth of human pluripotent stem cells. Nat. Mater. 2010, 9 (9), 768-778; (c) Luo, W.; 
Yousaf, M. N., Tissue Morphing Control on Dynamic Gradient Surfaces. J. Am. Chem. 
Soc. 2011, 133 (28), 10780-10783. 
6. Iwasaki, H.; Akashi, K., Hematopoietic developmental pathways: on cellular 
basis. Oncogene 2007, 26 (47), 6687-6696. 
 89 
7. Kiel, M. J.; Yilmaz, O. H.; Iwashita, T.; Yilmaz, O. H.; Terhorst, C.; Morrison, S. 
J., SLAM Family Receptors Distinguish Hematopoietic Stem and Progenitor Cells and 
Reveal Endothelial Niches for Stem Cells. Cell 2005, 121 (7), 1109-1121. 
8. (a) Kulp, K. S.; Berman, E. S. F.; Kinze, M. G.; Shattuck, D. L.; Nelson, E. J.; Wu, 
L.; Montgomery, J. L.; Felton, J. S.; Wu, K. J., Chemical and biological differentiation of 
three human breast cancer cell types using time-of-flight secondary ion mass 
spectrometry. Anal. Chem. 2006, 78, 3651-3658; (b) Kurczy, M. E.; Piehowski, P. D.; 
Van Bell, C. T.; Heien, M. L.; Winograd, N.; Ewing, A. G., Mass spectroscopy imaging of 
mating Tetrahymena show that changes in cell morphology relate to lipid domain 
formation. Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (7), 2751-2756; (c) Ostrowski, S. G.; 
Van Bell, C. T.; Winograd, N.; Ewing, A. G., Mass spectrometric imaging of highly 
curved membranes during tetrahymena mating. Science 2004, 305 (5680), 71-73. 
9. (a) Graham, D. J.; Wagner, M. S.; Castner, D. G., Information from complexity: 
Challenges of TOF-SIMS data interpretation. Appl. Surf. Sci. 2006, 252, 6860-6868; (b) 
Berman, E. S. F.; Wu, L.; Fortson, S. L.; Kulp, K. S.; Nelson, D. O.; Wu, K. J., 
Chemometric and statistical analyses of ToF-SIMS spectra of increasingly complex 
biological samples. Surf. Interface Anal. 2009, 41 (2), 97-104; (c) Magnusson, Y. K.; 
Friberg, P.; Sjovall, P.; Malm, J.; Chen, Y., TOF-SIMS Analysis of Lipid Accumulation in 
the Skeletal Muscle of ob/ob Mice. Obesity 2008, 16 (12), 2745-2753; (d) Anderton, C. 
R.; Vaezian, B.; Lou, K.; Frisz, J. F.; Kraft, M. L., Identification of a lipid-related peak set 
to enhance the interpretation of TOF-SIMS data from model and cellular membranes. 
Surf. Interface Anal. 2012, 44, 322-333; (e) Vaezian, B.; Anderton, C. R.; Kraft, M. L., 
Discriminating and Imaging Different Phosphatidylcholine Species within Phase-
Separated Model Membranes by Principal Component Analysis of TOF-SIMS Images. 
Anal. Chem. 2010, 82 (24), 10006-10014; (f) Berman, E. S. F.; Kulp, K. S.; Knize, M. G.; 
Wu, L.; Nelson, E. J.; Nelson, D. O.; Wu, K. J., Distinguishing Monosaccharide Stereo- 
and Structural Isomers with TOF-SIMS and Multivariate Statistical Analysis. Anal. 
Chem. 2006, 78 (18), 6497-6503; (g) Baker, M. J.; Brown, M. D.; Gazi, E.; Clarke, N. 
W.; Vickerman, J. C.; Lockyer, N. P., Discrimination of prostate cancer cells and non-
malignant cells using secondary ion mass spectrometry Analyst 2008, 113, 175-179; (h) 
Jungnickel, H.; Jones, E. A.; Lockyer, N. P.; Oliver, S. G.; Stephens, G. M.; Vickerman, 
J. C., Application of TOF-SIMS with Chemometrics to Discriminate between Four 
Different Yeast Strains from the Species Candida glabrata and Saccharomyces 
cerevisiae. Anal. Chem. 2005, 77, 1740-1745; (i) Thompson, C. E.; Fletcher, J. S.; 
Goodacre, R.; Henderson, A.; Lockyer, N. P.; Vickerman, J. C., ToF-SIMS studies of 
Bacillis using miltivariate analysis with possible identification and taxonomic 
applications. Appl. Surf. Sci. 2006, 252, 6719-6722; (j) Thompson, C. E.; Jungnickel, H.; 
Lockyer, N. P.; Stephens, G. M.; Vickerman, J. C., ToF-SIMS studies as a tool to 
discriminate between spoors and vegetative cells of bacteria. Appl. Surf. Sci. 2004, 231-
232, 420-423; (k) May, C. J.; Canavan, H. E.; Castner, D. G., Quantitative X-ray 
Photoelectron Spectroscopy and Time-of-Flight Secondary Ion Mass Spectrometry 
Characterization of the Components in DNA. Anal. Chem. 2004, 76, 1114-1122; (l) 
Wagner, M. S.; Castner, D. G., Characterization of Adsorbed Protein Films by Time-of-
Flight Secondary Ion Mass Spectrometry with Principal Component Analysis. Langmuir 
2001, 17, 4649-4660. 
 90 
10. Barnes, C. A.; Brison, J.; Robinson, M.; Graham, D. J.; Castner, D. G.; Ratner, B. 
D., Identifying Individual Cell Types in Heterogeneous Cultures Using Secondary Ion 
Mass Spectrometry Imaging with C60 Etching and Multivariate Analysis. Anal. Chem. 
2012, 84 (2), 893-900. 
11. Freshney, R. I., Introduction. In Culture of Animal Cells: A Manual of Basic 
Technique and Specialized Applications, 6th ed.; John Wiley & Sons, Inc.: Hoboken, 
New Jersey, 2010; pp 1-10. 
12. Tokoyoda, K.; Egawa, T.; Sugiyama, T.; Choi, B. I.; Nagasawa, T., Cellular 
niches controlling B lymphocyte behavior within bone marrow during development. 
Immunity 2004, 20 (6), 707-18. 
13. (a) Chambers, S. M.; Shaw, C. A.; Gatza, C.; Fisk, C. J.; Donehower, L. A.; 
Goodell, M. A., Aging Hematopoietic Stem Cells Decline in Function and Exhibit 
Epigenetic Dysregulation. PLoS Biol 2007, 5 (8), e201; (b) Mayack, S. R.; Shadrach, J. 
L.; Kim, F. S.; Wagers, A. J., Systemic signals regulate ageing and rejuvenation of 
blood stem cell niches. Nature 2010, 463 (7280), 495-500; (c) Warren, L. A.; Rossi, D. 
J., Stem cells and aging in the hematopoietic system. Mech. Ageing Dev. 2009, 130 (1-
2), 46-53. 
14. Passegue, E.; Jamieson, C. H.; Ailles, L. E.; Weissman, I. L., Normal and 
leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem 
cell characteristics? Proc. Natl. Acad. Sci. U.S.A. 2003, 100 Suppl 1, 11842-9. 
15. (a) Chen, Y.-W.; Lin, M.-S.; Vora, K. A., B cell differentiation: I. Development and 
functional analysis of murine B cells immortalized by a recombinant retrovirus. Int. 
Immunol. 1992, 4 (11), 1293-1302; (b) Schroeder, T., Hematopoietic Stem Cell 
Heterogeneity: Subtypes, Not Unpredictable Behavior. Cell Stem Cell 2010, 6 (3), 203-
207; (c) das Neves, R. P.; Jones, N. S.; Andreu, L.; Gupta, R.; Enver, T.; Iborra, F. J., 
Connecting Variability in Global Transcription Rate to Mitochondrial Variability. PLoS 
Biol. 2010, 8 (12), e1000560. 
16. (a) Jia, Y.; Loison, F.; Hattori, H.; Li, Y.; Erneux, C.; Park, S. Y.; Gao, C.; Chai, 
L.; Silberstein, L. E.; Schurmans, S.; Luo, H. R., Inositol trisphosphate 3-kinase B 
(InsP3KB) as a physiological modulator of myelopoiesis. Proc. Natl. Acad. Sci. U.S.A. 
2008, 105 (12), 4739-44; (b) Rumfelt, L. L.; Zhou, Y.; Rowley, B. M.; Shinton, S. A.; 
Hardy, R. R., Lineage specification and plasticity in CD19- early B cell precursors. J. 
Exp. Med. 2006, 203 (3), 675-87. 
17. Challen, G. A.; Boles, N.; Lin, K. K.; Goodell, M. A., Mouse hematopoietic stem 
cell identification and analysis. Cytometry A 2009, 75 (1), 14-24. 
18. Oran, U.; Unveren, E.; Wirth, T.; Unger, W. E. S., Poly-dimethyl-siloxame 
(PDMS) contamination of polystyrene (PS) oligomers samples: a comparison of time-of-
flight static secondary ion mass spectrometry (TOF-SSIMS) and X-ray photoelectron 
spectroscopy (XPS) results. Appl. Sur. Sci. 2004, 227, 318-324. 
19. Xia, N.; Castner, D. G., Preserving the structure of adsorbed protein films for 
time-of-flight secondary ion mass spectrometry analysis. J. Biomed. Mat. Res. 2003, 
67A, 179-190. 
20. Wise, B. M.; Gallagher, N. B.; Bro, R.; Shaver, J. M.; Windig, W.; Koch, R. S., 
PLS_Toolbox 4.0 for use with MATLAB. Eigenvector Research, Inc.: Wenatchee, 2006. 
21. (a) Norman, L.; Oetama, R.; Dembo, M.; Byfield, F.; Hammer, D.; Levitan, I.; 
Aranda-Espinoza, H., Modification of Cellular Cholesterol Content Affects Traction 
 91 
Force, Adhesion and Cell Spreading. Cell. Mol. Bioeng. 2010, 3 (2), 151-162; (b) Hayes, 
T. L.; Lindgren, F. T.; Gofman, J. W., A quantitative determination of the osmium 
tetroxide-lipoprotein interaction. J. Cell Biol. 1963, 19 (1), 251-255. 
22. (a) Chong, I.-G.; Jun, C.-H., Performance of some variable selection methods 
when multicollinearity is present. Chemo. Intell. Lab. Sys. 2005, 78 (1-2), 103-112; (b) 
Musumarra, G.; Barresi, V.; Condorelli, D. F.; Fortuna, C. G.; Scirè, S., Potentialities of 
multivariate approaches in genome-based cancer research: identification of candidate 
genes for new diagnostics by PLS discriminant analysis. J. Chemometrics 2004, 18 (3-
4), 125-132. 
23. (a) Brown, J.; Greaves, M. F.; Molgaard, H. V., The gene encoding the stem cell 
antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell 
lines, brain, and embryonic fibroblasts. Int. Immunol. 1991, 3 (2), 175-184; (b) Tang, C.; 
Lee, A. S.; Volkmer, J.-P.; Sahoo, D.; Nag, D.; Mosley, A. R.; Inlay, M. A.; Ardehali, R.; 
Chavez, S. L.; Pera, R. R.; Behr, B.; Wu, J. C.; Weissman, I. L.; Drukker, M., An 
antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of 
teratoma-forming cells. Nat. Biotech. 2011, 29 (9), 829-834. 
24. (a) Holst, J.; Watson, S.; Lord, M. S.; Eamegdool, S. S.; Bax, D. V.; Nivison-
Smith, L. B.; Kondyurin, A.; Ma, L.; Oberhauser, A. F.; Weiss, A. S.; Rasko, J. E. J., 
Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem 
and progenitor cells. Nat. Biotech. 2010, 28 (10), 1123-1128; (b) Lutolf, M. P.; 
Doyonnas, R.; Havenstrite, K.; Koleckar, K.; Blau, H. M., Perturbation of single 
hematopoietic stem cell fates in artificial niches. Integr. Biol. 2009, 1 (1), 59-69; (c) 
Rieger, M. A.; Schroeder, T., Exploring hematopoiesis at single cell resolution. Cells 
Tissues Organs 2008, 188 (1-2), 139-49; (d) Yilmaz, O. H.; Kiel, M. J.; Morrison, S. J., 
SLAM family markers are conserved among hematopoietic stem cells from old and 
reconstituted mice and markedly increase their purity. Blood 2006, 107 (3), 924-930. 
25. Houtkooper, R. H.; Argmann, C.; Houten, S. M.; Canto, C.; Jeninga, E. H.; 
Andreux, P. A.; Thomas, C.; Doenlen, R.; Schoonjans, K.; Auwerx, J., The metabolic 
footprint of aging in mice. Sci. Rep. 2011, 1. 
26. Basaiawmoit, R. V.; Rattan, S. I. S., Cellular Stress and Protein Misfolding During 
Aging. In Protein Misfolding and Cellular Stress in Disease and Aging: Concepts and 
Protocols, Bross, P.; Gregersen, N., Eds. Humana Press: New York, 2010; Vol. 648, pp 
107-117. 
27. Lhoest, J.-B.; Wagner, M. S.; Tidwell, C. D.; Castner, D. G., Characterization of 
adsorbed protein films by time of flight secondary ion mass spectrometry. J. Biomed. 
Mat. Res. 2001, 57, 432-440. 
28. Touboul, D.; Kollmer, F.; Niehuis, E.; Brunelle, A.; Laprévote, O., Improvement of 
Biological Time-of-Flight-Secondary Ion Mass Spectrometry Imaging with a Bismuth 
Cluster Ion Source. J. Am. Soc. Mass Spectrom. 2005, 16 (10), 1608-1618. 
 
 
 
  92 
Chapter 5 
Quantifying Cholesterol Concentration in Supported Lipid Membranes by TOF-
SIMS and Multivariate Analysis 
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Introduction 
Cholesterol is a cell membrane component whose abundance influences a 
diverse assortment of fundamental cellular processes, including endocytosis, 
intracellular vesicle transport, and cell adhesion.1  Cholesterol is unevenly distributed 
between the membranes of cellular organelles, transitioning from low abundance at the 
beginning of the secretory pathway to high abundance at the end.2 In addition, 
differential affinities between cholesterol and various lipid species are postulated to 
drive the formation of functionally distinct plasma membrane domains that are enriched 
with cholesterol and select lipid species.3  Because changes in not only the total 
intracellular cholesterol level, but also the cholesterol distribution among organelles and 
within individual membranes have been linked to disease, the mechanisms that control 
cholesterol distribution in biological membranes are the subject of much research.4   
A variety of techniques have been employed to investigate the exchange and 
distribution of cholesterol between and within model membranes.  Cholesterol transfer 
between membranes is usually quantified by using quartz crystal microbalance (QCM) 
or with radiometric techniques.5  The distribution of cholesterol within a membrane is 
often inferred from the membrane’s local biophysical properties.6 Though fluorescent 
cholesterol analogs can be directly visualized in membranes, the distribution of the 
fluorescent analog between lipid phases may differ from that of unlabeled cholesterol.7  
Time-of-flight secondary ion mass spectrometry (TOF-SIMS) is one of the few 
techniques that permit directly imaging the cholesterol distribution in membranes 
without the use of labels.8  By using TOF-SIMS to map the intensities of the cholesterol-
specific fragment ions within phase-separated supported membranes, the preferential 
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associations of cholesterol with sphingomyelin and dipalmitoylphosphatidyl-
ethanolamine have been imaged.8a-d  
The ability to quantify the cholesterol concentration at specific locations in model 
membranes would facilitate identifying the factors that control cholesterol distribution 
among and within biological membranes.  Presently, cholesterol transfer can be 
quantified with the methods mentioned above (i.e., QCM or radiometric methods),5 
whereas cholesterol content within different lipid phases can be measured with nuclear 
magnetic resonance (NMR).9 However, a chemically specific and quantitative imaging 
method is required to permit correlating membrane composition with morphology or 
location.  Though TOF-SIMS can image unlabeled cholesterol with location specificity,8a-
d the secondary ion yields are influenced by the local chemical environment, so 
secondary ion intensities are not directly proportional to the parent molecule’s 
concentration.8a, b, 10  Various SIMS techniques have been combined with selective 
isotope labeling to permit measuring the abundances of specific membrane 
components,6a, 11 but the need for isotope labels complicates sample preparation.  A 
label-free TOF-SIMS approach has been used to quantify changes in relative 
cholesterol abundance, but the absolute cholesterol concentration was not 
determined.12  Previous reports demonstrate that multivariate analysis enables 
extracting quantitative compositional information from TOF-SIMS data.13  For example, 
the compositions of unlabeled polymers and protein films have been quantified by 
constructing multivariate models of TOF-SIMS data from samples of known 
composition.13a-c Although multivariate analysis of TOF-SIMS data has been used to 
discriminate and image unlabeled lipids according to combinations of the low mass 
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fragment ions that are common to multiple lipid species,14 multivariate analysis has not 
been employed to quantify membrane composition. 
In this report, we quantified the cholesterol concentrations within supported lipid 
membranes by applying a multivariate analysis technique, partial least squares 
regression (PLSR), to TOF-SIMS data.  A PLSR model was constructed from the 
spectra of model membranes that varied in cholesterol concentration (calibration 
samples), and used to measure the cholesterol concentrations in a test set of supported 
lipid membranes.  The accuracy of the PLSR measurements was assessed by 
comparison to the cholesterol concentrations that were independently measured with 
enzymatic assays.  We show that by applying the TOF-SIMS/PLSR model to a single 
spectrum acquired at a small region in a supported lipid membrane, the cholesterol 
concentrations could be measured with an accuracy of a few mol%.  We also used this 
TOF-SIMS/PLSR approach to quantify cholesterol transfer between vesicles and 
discrete regions within supported lipid membranes. 
Materials and Methods 
Preparation of Homogeneous Supported Lipid Membranes  
1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), cholesterol, 1-palmitoyl-2-[12- 
[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]lauroyl]-sn-glycero 3- phosphocholine (NBD-
PC), and 1,2-stearoyl-sn-glycero-3-phosphocholine (DSPC) were purchased from 
Avanti Polar Lipids (Alabaster, AL) and used without further purification. Millipore water 
(18 MΩ) was used for all experiments.  Oxidized silicon substrates that were patterned 
with a chrome grid were fabricated as previously reported.11b  Lipid mixtures consisting 
of various molar percentages (mol%) of DLPC (79 to 99 mol%) and cholesterol (0 to 20 
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mol%) plus 1 mol% NBD-PC for visualization with fluorescence microscopy were 
dissolved in chloroform and dried under vacuum to remove the solvent.  The lipid film 
was resuspended in room temperature water to a final lipid concentration of 0.5 mg/mL.  
This lipid solution was vortexed 4 times over a period of 15 min.  Next the lipid solution 
was transferred to a 50 mL plastic centrifuge tube and sonicated using a tip sonicator 
(Branson Tip Sonifier Model 250, Branson Ultrasonics, Danbury CT) for 2 minutes in 
cycles of 30 s on and 30 s off.   Immediately, 2.5 mL of the vesicle solution was added 
to a 60-mm- diameter × 15-mm-tall polystyrene culture dish containing multiple chrome-
patterned, oxidized silicon substrates submerged in 2.5 mL of water.  Samples were 
covered and incubated at room temperature for 30 min.  The substrates were 
transferred to a room temperature water bath and shaken for 45 s under water to 
dislodge vesicles attached to the bilayer’s surface, transferred to a fresh bath and 
shaken again.  To prepare the substrates for SIMS analysis, the substrates were flash-
frozen in liquid ethane and freeze dried as perviously described.15,38  Fluorescence 
microscopy (Leica DM6000 B, Q-Imaging EXi Blue Fluorescence Microscope) was used 
to evaluate membrane quality.  Sample mosaics, which enabled analysis of specific 
locations with TOF-SIMS, were also made by fluorescence microscopy. 6a, 14b   
Cholesterol Assay   
The actual cholesterol concentration in each cholesterol-containing vesicle 
solution used to form a supported lipid bilayer was measured with the Amplex® Red 
Cholesterol Assay Kit and Amplex® Red Phospholiase D Assay Kit (Invitrogen).6a  The 
assays were performed in 96-well plates purchased from Costar® (Corning, NY), and 
the fluorescence intensity was read using a Synergy HT Multi-Mode Microplate Reader 
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Model SIAFRT (Biotek® Instruments, Inc., Winooski, VT). Cholesterol and PC 
standards were used to create the calibration curves. Eight replicate measurements 
were made on each vesicle solution, and the mean (µ) ± one standard deviation (σ) are 
reported for each sample.  The cholesterol concentration in each supported lipid 
membrane was assumed to be the same as that in the vesicle solution used for bilayer 
formation.  A mosaic of fluorescence microscopy images (Leica DM6000 B, Q-Imaging 
EXi Blue Fluorescence Microscope) was created of each flash-frozen and freeze-dried 
membrane to facilitate analyzing specific sample locations with TOF-SIMS.6a 
Preparation of Supported Lipid Membrane with a Composition Gradient  
A supported membrane with a spatial variation in composition was made from 
two different vesicle solutions (99/0/1 and 82/17/1 mol%/mol%/mol% 
DLPC/cholesterol/NBD-PC) following the previously reported procedure.11a The chrome-
patterned oxidized silicon substrate was incubated on top of the two droplets (each 2 
µL) of vesicle solutions for 30 min at room temperature (RT), rinsed in fresh water to 
remove the excess vesicles, flash-frozen, and freeze-dried.   
Exchange Membrane Sample Preparation  
Exchange membrane samples with two different compositions were prepared.  
Samples with composition 1 were cholesterol-free supported lipid membranes that were 
exposed to vesicles containing 17 ± 1 mol% cholesterol. Samples with composition 2 
were 19 ± 1 mol% cholesterol supported lipid membranes that were exposed to 
cholesterol-free vesicles. To create samples with compositions 1 and 2, chrome-
patterned oxidized silicon substrates in a petri dish were covered with 2.4 mL of water, 
and then 2.4 mL of a 0.5 mg/mL vesicle solution composed of 99/0/1 or 80/19/1 
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mol%/mol%/mol% DLPC/cholesterol/NBD-PC, respectively, was added to the dish.  
After 30 min at RT, 2.4 mL of a 0.5 mg/mL vesicle solution composed of 82/17/1 or 
99/0/1 mol%/mol%/mol% DLPC/cholesterol/NBD-PC was added to the dish that 
contained samples with compositions 1 and 2, respectively.  Each dish was incubated 
for another 30 min at RT, and then the supported membranes were rinsed, flash-frozen, 
and freeze-dried. 
TOF-SIMS  
TOF-SIMS was performed on a PHI Trift-III TOF-SIMS (Physical Electronics 
Incorporated, Chanhassen, MN) using a 22 kV 197Au+ primary ion beam. TOF-SIMS 
data were acquired in unbunched mode from 50 µm by 50 µm or 40 µm by 40 µm 
membrane regions that exhibited uniform fluorescence intensities.  Several different 
locations were analyzed on each homogeneous lipid membrane sample.  Positive ion 
spectra were obtained with a mass range of 0 – 800 amu and a mass resolution of 
M/∆M 1433 at the 184 m/z peak.  An ion dose of 3 x 1013 ions/cm2 was used for all 
analyses. 
Data Analysis  
Unit mass binned spectra were extracted from sample locations that 
corresponded to the membrane, and not the chrome grid, using Wincadence software.  
Mass peaks outside of the m/z 50 to 300 range were removed from the spectra. The 
intensities of the peaks above 300 m/z, which include the DLPC and cholesterol 
molecular ions, were too low to be reproducibly detected with our instrumentation, and 
peaks below m/z 50 are not chemically specific.15 Peaks from the chrome grid (m/z 52) 
and polydimethylsiloxane (PDMS) contamination (m/z 73, 147, 207, 221, and 281)16 
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were also removed from the spectra.  Note that the PDMS contamination and a major 
cholesterol fragment at m/z 1478e could not be resolved in these experiments; we 
experimentally found that better accuracy was obtained when peak m/z 147 was 
excluded.  PLSR was performed on the data using the PLS Toolbox (v6.7.1, 
Eigenvector Research, Manson, WA) for MATLAB (7.14.0.739, R2012a, MathWorks 
Inc., Matick, MA).  Each peak was normalized to the total intensity of the remaining 
peaks in the spectrum, and the spectra were mean-centered. The spectra that were 
used for model construction (calibration spectra) were loaded in the x-block, the actual 
mol% cholesterol in the calibration samples was loaded into the y-block, and a 
preliminary PLSR model was constructed. Samples with Y-student residual values 
outside of ± 1.2 or leverage values > 0.1 were removed from the preliminary model.  
When the majority of the spectra acquired from a single sample had either high 
leverage or Y-student residuals, all of the spectra acquired from the sample were 
omitted from further analysis.  Cross validation was performed using a random subset 
with 10 splits and 5 iterations. The PLSR model was applied to the spectra of test lipid 
membranes that were not used for model construction to measure their cholesterol 
concentrations.     
Results 
Measuring Cholesterol Concentration in Homogeneous Supported Lipid 
Membranes by PLSR of TOF-SIMS Data   
A PLSR model was constructed of numerous spectra from seven homogeneous 
supported DLPC membranes with cholesterol concentrations that ranged between 0 
and 20 mol% (calibration samples).  This range of cholesterol concentrations was 
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selected because high-quality membranes did not form when higher cholesterol levels 
were employed.6a The final PLSR model consisted of five latent variables (LVs) that 
captured 99% of the mass spectral variance (50%, 36%, 7%, 4% and 2% of the spectral 
variance was captured by LV 1, 2, 3, 4, and 5, respectively), and 98% of the variance in 
the cholesterol concentration (36%, 19%, 25%, 8% and 10% of the variance in the 
mol% cholesterol was captured by LV 1, 2, 3, 4, and 5, respectively).  Though most of 
the spectral variance was captured with the first three LVs, LV 4 and 5 captured 18% of 
the variance in the cholesterol concentration, and their inclusion improved model 
accuracy. Additional LVs did not significantly increase the variance captured by the 
model or its accuracy, so they were not included in the final model. 
The PLSR model was validated by using it to measure the cholesterol 
concentrations in the calibration samples and four homogeneous supported DLPC 
membrane samples with known cholesterol concentrations that were not used for model 
construction (test samples). All of these samples had been prepared and analyzed with 
TOF-SIMS over period of approximately 12 months. The mean (µ) mol% cholesterol 
and the standard deviation (σ) of the individual TOF-SIMS/PLSR measurements made 
on each homogeneous lipid membrane in the calibration and test sets are listed in 
Table 5.1. The cholesterol concentrations measured for the calibration samples were 
nearly identical to the actual cholesterol concentrations that were measured with 
enzymatic assays.  The cholesterol concentrations (2 ± 1, 4± 1, 15 ± 1 and 21 ± 1 
mol%) measured in the four test DLPC membranes by TOF-SIMS/PLSR were also in 
good agreement with the actual mol% cholesterol (0, 4 ± 1, 13 ± 1 and 19 ± 1 mol%, 
respectively). This demonstrates that the cholesterol concentration-specific spectral 
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variation did not change due to instrumental drift over the year in which the TOF-SIMS 
data were acquired, enabling accurate measurement of cholesterol concentration.   
Table 5.1 Cholesterol concentrations in calibration and test supported lipid membranes, where 
the actual mol% cholesterol in the membranes that contained cholesterol was measured with 
conventional assays (see Materials and Methods). 
 
 Actual 
mol% 
cholesterol 
(µ ± σ) 
mol % cholesterol 
measured by 
TOF-SIMS/PLSR 
(µ ± σ) 
Regions 
analyzed 
Calibration 
samples 
0 1 ± 1 13 
0 0 ± 1 14 
4 ± 2 5 ± 1 12 
10 ± 1 8 ± 1 8 
14 ± 1 14 ± 1 14 
17 ± 1 17 ± 1 15 
19 ± 1 19 ± 1 12 
20 ± 2 20 ± 1 16 
Test 
samples 
0 2 ± 1 11 
4 ± 1 4 ± 1 14 
13 ± 1 15 ± 1 17 
19 ± 1 21 ± 1 12 
 
To acquire location specific compositional data, the PLSR model must be applied 
to a single spectrum acquired at the region of interest.  Therefore, we also investigated 
the precision and accuracy of the PLSR measurements made with each individual 
spectrum. The cholesterol concentrations measured by TOF-SIMS/PLSR of the 
individual spectra acquired from the calibration and test lipid membranes are shown in 
Figure 5.1a.   
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Figure 5.1 A) Identification of mol% cholesterol in calibration and test supported DLPC 
membranes by PLSR of TOF-SIMS data.  The spectra from seven DLPC membranes of known 
cholesterol concentration (calibration samples) were used to construct the PLSR model. The 
PLSR model was then used to re-assess the mol% cholesterol in the calibration samples, and to 
measure the cholesterol concentration in DLPC membranes of known composition that were not 
used for model construction (test samples).  (A) Graph shows the mol% cholesterol determined 
by PLSR at each location that a spectrum was acquired on the calibration (cal) and test 
membranes.   (B) VIP scores plot shows which peaks have VIP scores > 1 (red dashed line), 
and thus, are important for determining the cholesterol concentration in the membrane.   
 
The range of the individual measurements that were made on the same 
membrane was almost always less than 4 mol% cholesterol.  Moreover, the individual 
PLSR/TOF-SIMS measurements were usually within 3 mol% of the actual cholesterol 
concentrations measured with conventional assays (Table 5.3).  This ability to measure 
the cholesterol concentration with good accuracy and precision by applying the PLSR 
model to a single spectrum will enable quantifying cholesterol abundance at locations of 
interest in a membrane. 
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The importance of each peak towards identifying the cholesterol concentration is 
shown in the variable importance of projection (VIP) scores plot (Figure 5.1b).  Peaks 
related to cholesterol (m/z 105, 107)8e, 17 and lipids (m/z 58, 59, 86 and 184)14a have VIP 
scores greater than unity (Figure 5.1b), and thus, their normalized intensities vary 
according to the cholesterol concentration in the membrane. The high importance of the 
hydrocarbon peaks that are common to both lipids and cholesterol (m/z 55, 57, 91, and 
95)8e, 17 suggests that the relative intensities of these peaks vary between the 
cholesterol and lipid spectra.  Because the PLSR model related differences in relative 
intensities of the lipid- and cholesterol-related fragment ions to the mol% cholesterol in 
the membrane, accurate measurements were obtained despite our use of unit mass 
binned spectra with a limited mass range.  However, we expect that this accuracy could 
be further improved by acquiring spectra with a TOF-SIMS instrument that reproducibly 
detects the more component-specific high mass (m/z >300) secondary ions with high 
mass resolving power.  Exploitation of the relative intensities of the lipid and cholesterol 
fragment ions to identify cholesterol concentration also had disadvantages; the lipid-
related peaks were specific to DLPC, so the application of this model was limited to 
DLPC membranes.  This PLSR model did not accurately predict the cholesterol 
concentrations in membranes composed of DSPC, which has longer fatty acid tails than 
DLPC, likely because DLPC produces a higher ratio of headgroup to tail group fragment 
ions than DSPC.14b  Consequently, a new PLSR model would need to be constructed to 
measure the cholesterol concentration in membranes that contain different lipid species.   
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Prediction of Cholesterol Concentration in a Supported Lipid Membrane with a 
Compositional Gradient 
As a proof of concept, the TOF-SIMS/PLSR model was used to quantify the 
cholesterol concentration at regions of interest within a supported lipid membrane that 
exhibited a lateral gradient in composition. This compositional gradient membrane was 
created by exposing an oxidized silicon substrate that was patterned with a chrome grid 
to two adjacent droplets (2 µL each) of 99/0/1 and 82/17/1 mol%/mol%/mol% 
DLPC/cholesterol/NBD-PC vesicle solutions such that the two droplets came into 
contact and mixed as the vesicles within them fused to the substrate (Figure 5.2A).  
Because vesicle fusion is usually faster than droplet mixing,11a the composition of the 
resulting membrane would vary from 0 to 17 mol% cholesterol from one side of the 
substrate to the other if cholesterol transfer between the vesicles and/or the supported 
membrane was negligible.  However, cholesterol spontaneously transfers from vesicles 
with high cholesterol/lipid ratios to model and cellular membranes with lower ratios,5a, 5c, 
d, 18 so the supported membrane would likely have a smaller range of cholesterol 
concentrations.  Note that lipid components within a supported lipid membranes can 
diffuse laterally within the corralled region, but cannot cross the chrome grid or 
spontaneously transfer between membranes under these conditions.5d, 11a As a result, 
the membrane composition in each corralled region was homogeneously mixed, but the 
composition within each corral varied across the substrate.    
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Figure 5.2 (A) Preparation of cholesterol gradient sample.  A droplet each of 99/0/1 (red) and 
82/17/1 (white) mol%/mol%/mol% DLPC/cholesterol/NBD-PC vesicle solution were placed on a 
glass coverslip approximately 2 mm apart, and an oxidized silicon substrate with a chrome grid 
was placed face down over the droplets for 30 min.  (B) Mosaic of fluorescent microscopy 
images of the resulting freeze-dried supported lipid membrane. The fluorescent squares are the 
membrane patches within the chrome grid, which appears dark. Regions where the membrane 
was disrupted during freeze drying are intensely fluorescent (i.e., bottom left).  The periodic 
variations in fluorescence intensity are caused by uneven illumination within the individual 
images that make up the mosaic. Numbers indicate the locations where spectra were acquired 
with TOF-SIMS.  Based on the positions of the scratches on the substrate (thick dark lines), the 
cholesterol concentration should increase from left to right. (C) Mol% cholesterol measured by 
TOF-SIMS/PLSR at each numbered region shown in (B). TOF-SIMS/PLSR measured (µ ± σ) 6 
± 0, 5 ± 1, 9 ± 1, 19 ± 2, and 19 ± 2 mol% cholesterol at regions 1 – 8, 9 – 16, 17 – 21, 22 – 24, 
and 25 – 30, respectively.  
 
The fluorescence microscopy images of the freeze-dried supported lipid 
membrane show the locations where spectra were collected (Figure 5.2B). Based on 
the scratches that were made on the substrate prior to membrane formation to facilitate 
orienting the sample, the cholesterol concentrations in the corralled membrane patches 
were expected to increase from the left side of the substrate to the right.  Consistent 
with this expectation, the maximum cholesterol concentration (µ ± σ) was measured by 
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TOF-SIMS/PLSR at the lower right side of the substrate (19 ± 2 mol% for both regions 
25 – 30 and 22 – 24), and the cholesterol concentration decreased as the analysis 
location moved up (9 ± 1 mol% at regions 17 – 21) and to the left (5 ± 1 mol% at regions 
9 – 16) on the substrate (Figure 5.2C).  The 19 ± 2 mol% cholesterol measured at the 
right side of the substrate was slightly higher than that in the vesicles deposited at this 
location (17 ± 1 mol%).  We conclude this 2 mol% difference represents measurement 
error and no net cholesterol transfer occurred at these supported membrane locations 
because cholesterol transfers in the direction of, and not against, a concentration 
gradient, and phospholipid transfer is insignificant under these conditions.5c, d However, 
the 6 ± 0 mol% cholesterol measured at the left side of the substrate (regions 1 – 8) is 
significantly higher than that in the vesicles deposited at that location (0 mol%).  This 
suggests that cholesterol transferred into the regions of the supported lipid membrane 
that were formed by the fusion of cholesterol-free vesicles.   
Next, we verified that the minimum cholesterol concentration measured in the 
gradient membrane was higher than that of the vesicles deposited at this region on the 
substrate (0 mol% cholesterol) due to cholesterol transfer, and not significant errors in 
the TOF-SIMS/PLSR measurements.  Cholesterol-free supported lipid membranes were 
incubated for 30 min in the presence of 17 ± 1 mol% cholesterol vesicles.  TOF-
SIMS/PLSR measured averages of 3 ± 1 to 5 ± 1 mol% cholesterol (Figure 5.3 and 
Table 5.2) in these exchange membranes, which are higher than that measured by 
TOF-SIM/PLSR in cholesterol-free test membranes that were not exposed to 
cholesterol-containing vesicles (2 ± 1 mol% cholesterol, Table 5.1).  This confirms that 
cholesterol transferred into the exchange membrane, though slightly (1 – 3 mol%) less 
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than that observed in the gradient membrane.  This small disparity is likely due to 
differences in the conditions used to prepare the gradient and exchange membranes 
(i.e., incubation media volumes, time between supported membrane formation and 
exposure to donor vesicles, ratio of cholesterol-free membrane surface area in the 
vesicles and supported membranes, and total vesicle and cholesterol concentrations in 
incubation media).  
 
Figure 5.3 Graph of the mol% cholesterol measured by PLSR of individual spectra from 
supported lipid membranes consisting of 0 or 19 ± 1 mol% cholesterol that were incubated in 
the presence of vesicles that contained 17 ± 1 or 0 mol% cholesterol, respectively. 
 
We also evaluated the validity of the maximum mol% cholesterol measured in the 
gradient membrane by assessing the cholesterol concentrations in 19 ± 1 mol% 
cholesterol supported membranes that were exposed to cholesterol-free vesicle 
solutions for 30 min.  As listed in Table 5.2, 17 ± 1 and 15 ± 1 mol% cholesterol were 
measured in these membranes with TOF-SIMS/PLSR. Thus, slightly less cholesterol 
transfer occurred when the donor was a supported lipid membrane than when the donor 
was a vesicle, which is consistent with previous reports that the rate of cholesterol 
transfer decreases with decreasing curvature of the donor membrane.5a, 5c, d, 6b, 18c  
These results also indicate that cholesterol efflux from the exchange membrane was 
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slightly higher than that from the gradient membrane.  Again, this slight discrepancy was 
likely caused by differences in the volume and composition of the incubation medium 
that the exchange and gradient membranes were exposed to. Overall, we conclude that 
the cholesterol concentrations measured in the compositional gradient supported lipid 
membrane by TOF-SIMS/PLSR were within a few mol% of the actual concentration.   
 
Table 5.2 Cholesterol concentrations measured by TOF-SIMS/PLSR in supported lipid 
membranes consisting of 0 or 19 ± 1 mol% cholesterol that were incubated for 30 min in the 
presence of vesicles containing 17 ± 1 or 0 mol% cholesterol, respectively.   The actual mol% 
cholesterol was in the vesicles containing cholesterol was measured with the assay described in 
the Materials and Methods. 
 
Actual mol% cholesterol 
supported membrane / 
vesicles (µ ± σ) 
mol% cholesterol 
measured by TOF-
SIMS/PLSR (µ ± σ) 
Regions 
analyzed 
0 / 17 ± 1 3 ± 0 10 
0 / 17 ± 1 5 ± 1 16 
0 / 17 ± 1 3 ± 1 17 
19 ± 1 / 0 15 ± 1 12 
19 ± 1 / 0 17 ± 1 11 
 
Conclusion 
We have used calibration spectra from membranes of known composition to 
develop a PLSR model that successfully captured the spectral variance that was 
correlated to mol% cholesterol, but not the spectral variation between membranes with 
the same mol% cholesterol.  The resulting PLSR model accurately measured the mol% 
cholesterol in DLPC membranes that were prepared and analyzed over the course of a 
year, demonstrating the robustness of this approach. The greatest accuracy in the 
cholesterol concentration measured by TOF-SIMS/PLSR was obtained when the PLSR 
model was applied to multiple spectra acquired from the membrane of interest.  
However, application of the PLSR model to a single spectrum yielded a cholesterol 
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concentration that was typically within 3 mol% of the actual composition, which enables 
accurately measuring the cholesterol concentration at a specific membrane location. 
Using this TOF-SIMS/PLSR approach, we found that cholesterol was more readily 
transferred from donor vesicles to cholesterol-deficient supported lipid membranes than 
from donor supported lipid membranes to cholesterol-deficient vesicles.  While the 
model used in this work was specific for DLPC/cholesterol membranes, analogous 
PLSR models can be constructed to permit quantifying the cholesterol concentrations in 
membranes composed of other lipid species (i.e., sphingomyelin).  This approach can 
be used to quantify cholesterol transfer between vesicles and discrete regions on 
supported lipid membranes, or to correlate the cholesterol concentration with the 
morphology of distinct domains in phase-separated supported lipid membranes.  
  
  110 
Table 5.3 Comparison of cholesterol concentrations measured with conventional assays and by 
PLSR of each spectrum from the calibration and test membranes 
 
 mol% cholesterol measured by:   
Sample TOF-
SIMS/PLSR 
Assay (mean of 
8 
measurements) 
absolute value 
(Assay - TOF-
SIMS/PLSR) 
0%_chol_cal_sample1_spectrum_1 0.2 0 0.2 
0%_chol_cal_sample1_spectrum_2 1.0 0 1.0 
0%_chol_cal_sample1_spectrum_3 1.4 0 1.4 
0%_chol_cal_sample1_spectrum_4 0.5 0 0.5 
0%_chol_cal_sample1_spectrum_5 0.8 0 0.8 
0%_chol_cal_sample1_spectrum_6 2.1 0 2.1 
0%_chol_cal_sample1_spectrum_7 2.0 0 2.0 
0%_chol_cal_sample1_spectrum_8 1.6 0 1.6 
0%_chol_cal_sample1_spectrum_9 1.1 0 1.1 
0%_chol_cal_sample1_spectrum_10 1.5 0 1.5 
0%_chol_cal_sample1_spectrum_11 1.3 0 1.3 
0%_chol_cal_sample1_spectrum_12 1.7 0 1.7 
0%_chol_cal_sample1_spectrum_13 0.8 0 0.8 
Average 1.2 0 1.2 
    
0%_chol_cal_sample2_spectrum_1 -0.7 0 0.7 
0%_chol_cal_sample2_spectrum_2 -1.7 0 1.7 
0%_chol_cal_sample2_spectrum_3 -1.2 0 1.2 
0%_chol_cal_sample2_spectrum_4 -1.8 0 1.8 
0%_chol_cal_sample2_spectrum_5 -1.2 0 1.2 
0%_chol_cal_sample2_spectrum_6 -1.4 0 1.4 
0%_chol_cal_sample2_spectrum_7 -0.9 0 0.9 
0%_chol_cal_sample2_spectrum_8 -0.9 0 0.9 
0%_chol_cal_sample2_spectrum_9 -0.3 0 0.3 
0%_chol_cal_sample2_spectrum_10 0.1 0 0.1 
0%_chol_cal_sample2_spectrum_11 -0.4 0 0.4 
0%_chol_cal_sample2_spectrum_12 0.5 0 0.5 
0%_chol_cal_sample2_spectrum_13 1.6 0 1.6 
0%_chol_cal_sample2_spectrum_14 1.0 0 1.0 
0%_chol_cal_sample2_spectrum_15 0.4 0 0.4 
Average -0.4   0.9 
     
4%_chol_cal_spectrum_1 4.5 3.9 0.6 
4%_chol_cal_spectrum_2 5.3 3.9 1.4 
4%_chol_cal_spectrum_3 5.0 3.9 1.1 
4%_chol_cal_spectrum_4 5.4 3.9 1.5 
4%_chol_cal_spectrum_5 4.8 3.9 0.9 
4%_chol_cal_spectrum_6 4.4 3.9 0.5 
4%_chol_cal_spectrum_7 4.4 3.9 0.4 
4%_chol_cal_spectrum_8 5.8 3.9 1.9 
4%_chol_cal_spectrum_9 6.2 3.9 2.3 
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Table 5.3 Continued 
 
   
4%_chol_cal_spectrum_10 4.8 3.9 0.8 
4%_chol_cal_spectrum_11 2.7 3.9 1.2 
4%_chol_cal_spectrum_12 3.3 3.9 0.6 
Average 4.7  1.1 
    
10%_chol_cal_spectrum_1 6.5 10.5 4.0 
10%_chol_cal_spectrum_2 9.3 10.5 1.2 
10%_chol_cal_spectrum_3 8.3 10.5 2.2 
10%_chol_cal_spectrum_4 7.8 10.5 2.7 
10%_chol_cal_spectrum_5 6.4 10.5 4.1 
10%_chol_cal_spectrum_6 5.9 10.5 4.6 
10%_chol_cal_spectrum_7 7.2 10.5 3.2 
10%_chol_cal_spectrum_8 9.7 10.5 0.8 
Average 7.6   2.8 
     
14%_chol_cal_spectrum_1 13.3 13.7 0.4 
14%_chol_cal_spectrum_2 13.6 13.7 0.1 
14%_chol_cal_spectrum_3 14.0 13.7 0.3 
14%_chol_cal_spectrum_4 13.9 13.7 0.2 
14%_chol_cal_spectrum_5 14.0 13.7 0.2 
14%_chol_cal_spectrum_6 14.9 13.7 1.2 
14%_chol_cal_spectrum_7 14.7 13.7 1.0 
14%_chol_cal_spectrum_8 14.2 13.7 0.5 
14%_chol_cal_spectrum_9 14.5 13.7 0.8 
14%_chol_cal_spectrum_10 14.9 13.7 1.1 
14%_chol_cal_spectrum_11 
14%_chol_cal_spectrum_12 
14.5 
14.1 
13.7 
13.7 
0.7 
0.4 
14%_chol_cal_spectrum_13 13.9 13.7 0.1 
14%_chol_cal_spectrum_14 11.5 13.7 2.2 
Average 14.0   0.7 
     
17%_chol_cal_spectrum_1 17.7 17.3 0.5 
17%_chol_cal_spectrum_2 16.8 17.3 0.5 
17%_chol_cal_spectrum_3 17.0 17.3 0.3 
17%_chol_cal_spectrum_4 17.6 17.3 0.4 
17%_chol_cal_spectrum_5 16.3 17.3 1.0 
17%_chol_cal_spectrum_6 16.9 17.3 0.3 
17%_chol_cal_spectrum_7 17.3 17.3 0.0 
17%_chol_cal_spectrum_8 16.6 17.3 0.6 
17%_chol_cal_spectrum_9 16.4 17.3 0.9 
17%_chol_cal_spectrum_10 18.5 17.3 1.2 
17%_chol_cal_spectrum_11 17.7 17.3 0.4 
17%_chol_cal_spectrum_12 17.4 17.3 0.2 
17%_chol_cal_spectrum_13 17.2 17.3 0.0 
17%_chol_cal_spectrum_14 17.0 17.3 0.3 
17%_chol_cal_spectrum_15 17.8 17.3 0.5 
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Average 17.2   0.5 
    
20%_chol_cal_sample1_spectrum_1 17.3 19.8 2.6 
20%_chol_cal_sample1_spectrum_2 19.6 19.8 0.3 
20%_chol_cal_sample1_spectrum_3 
20%_chol_cal_sample1_spectrum_4 
20.2 
21.3 
19.8 
19.8 
0.3 
1.4 
20%_chol_cal_sample1_spectrum_5 20.9 19.8 1.1 
20%_chol_cal_sample1_spectrum_6 20.5 19.8 0.7 
20%_chol_cal_sample1_spectrum_7 20.5 19.8 0.7 
20%_chol_cal_sample1_spectrum_8 18.0 19.8 1.8 
20%_chol_cal_sample1_spectrum_9 20.0 19.8 0.2 
20%_chol_cal_sample1_spectrum_10 20.2 19.8 0.4 
20%_chol_cal_sample1_spectrum_11 18.7 19.8 1.2 
20%_chol_cal_sample1_spectrum_12 19.3 19.8 0.5 
20%_chol_cal_sample1_spectrum_13 20.9 19.8 1.1 
20%_chol_cal_sample1_spectrum_14 20.7 19.8 0.9 
20%_chol_cal_sample1_spectrum_15 20.6 19.8 0.8 
20%_chol_cal_sample1_spectrum_16 18.0 19.8 1.8 
Average 19.8   1.0 
     
20%_chol_cal_sample2_spectrum_1 19.2 19.0 0.2 
20%_chol_cal_sample2_spectrum_2 18.9 19.0 0.1 
20%_chol_cal_sample2_spectrum_3 19.6 19.0 0.6 
20%_chol_cal_sample2_spectrum_4 17.9 19.0 1.1 
20%_chol_cal_sample2_spectrum_5 19.4 19.0 0.4 
20%_chol_cal_sample2_spectrum_6 19.4 19.0 0.4 
20%_chol_cal_sample2_spectrum_7 
20%_chol_cal_sample2_spectrum_8 
19.9 
19.7 
19.0 
19.0 
0.9 
0.7 
20%_chol_cal_sample2_spectrum_9 18.8 19.0 0.2 
20%_chol_cal_sample2_spectrum_10 18.7 19.0 0.3 
20%_chol_cal_sample2_spectrum_11 19.3 19.0 0.3 
20%_chol_cal_sample2_spectrum_12 17.9 19.0 1.1 
Average 19.0   0.5 
     
0%_chol_test_spectrum_1 1.9 0 1.9 
0%_chol_test_spectrum_2 1.6 0 1.6 
0%_chol_test_spectrum_3 1.1 0 1.1 
0%_chol_test_spectrum_4 1.6 0 1.6 
0%_chol_test_spectrum_5 1.4 0 1.4 
0%_chol_test_spectrum_6 2.4 0 2.4 
0%_chol_test_spectrum_7 1.2 0 1.2 
0%_chol_test_spectrum_8 2.0 0 2.0 
0%_chol_test_spectrum_9 2.2 0 2.2 
0%_chol_test_spectrum_10 2.3 0 2.3 
0%_chol_test_spectrum_11 2.1 0 2.1 
Average 1.8   1.8 
    
  113 
 
  
Table 5.3 Continued 
 
   
4%_chol_test_spectrum_1 3.4 4.0 0.6 
4%_chol_test_spectrum_2 3.2 4.0 0.8 
4%_chol_test_spectrum_3 2.4 4.0 1.5 
4%_chol_test_spectrum_4 3.2 4.0 0.8 
4%_chol_test_spectrum_5 4.3 4.0 0.3 
4%_chol_test_spectrum_6 5.3 4.0 1.3 
4%_chol_test_spectrum_7 4.8 4.0 0.8 
4%_chol_test_spectrum_8 2.7 4.0 1.3 
4%_chol_test_spectrum_9 3.9 4.0 0.1 
4%_chol_test_spectrum_10 4.0 4.0 0.1 
4%_chol_test_spectrum_11 2.7 4.0 1.3 
4%_chol_test_spectrum_12 4.9 4.0 1.0 
4%_chol_test_spectrum_13 2.7 4.0 1.3 
4%_chol_test_spectrum_14 1.7 4.0 2.2 
Average 3.5   1.0 
     
13%_chol_test_spectrum_1 13.8 13.4 0.4 
13%_chol_test_spectrum_2 14.2 13.4 0.9 
13%_chol_test_spectrum_3 14.2 13.4 0.8 
13%_chol_test_spectrum_4 11.7 13.4 1.7 
13%_chol_test_spectrum_5 15.9 13.4 2.6 
13%_chol_test_spectrum_6 15.5 13.4 2.2 
13%_chol_test_spectrum_7 16.3 13.4 3.0 
13%_chol_test_spectrum_8 16.5 13.4 3.2 
13%_chol_test_spectrum_9 13.0 13.4 0.3 
13%_chol_test_spectrum_10 13.6 13.4 0.2 
13%_chol_test_spectrum_11 15.3 13.4 2.0 
13%_chol_test_spectrum_12 15.9 13.4 2.5 
Average 14.7   1.6 
     
20%_chol_test_spectrum_1 20.7 19.0 1.7 
20%_chol_test_spectrum_2 21.6 19.0 2.6 
20%_chol_test_spectrum_3 21.2 19.0 2.2 
20%_chol_test_spectrum_4 20.6 19.0 1.6 
20%_chol_test_spectrum_5 19.8 19.0 0.8 
20%_chol_test_spectrum_6 21.0 19.0 2.0 
20%_chol_test_spectrum_7 21.8 19.0 2.8 
20%_chol_test_spectrum_8 20.0 19.0 1.1 
20%_chol_test_spectrum_9 21.4 19.0 2.4 
20%_chol_test_spectrum_10 21.9 19.0 2.9 
20%_chol_test_spectrum_11 21.8 19.0 2.8 
20%_chol_test_spectrum_12 21.3 19.0 2.3 
Average 21.1   2.1 
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Chapter 6 
 
Conclusion and future direction 
 
 
 Secondary ion mass spectrometry (SIMS) provides unique capabilities for 
investigating the organization and identity of various biological membranes.  This 
technique generates chemically specific information for cell membranes, without large 
structural modifications for labels or even avoid labels altogether.   
 The high resolution of NanoSIMS allows membrane organization to be probed 
with unprecedented chemical detail.  A specific label for proteins that is effective for 
detection with the NanoSIMS was developed and employed in conjunction with labeled 
lipids in the surrounding membrane.  This label was used to locate the influenza 
membrane protein hemagglutinin, which was thought to be confined to sphingolipid 
domains; however, no statistical elevation of hemagglutinin found in sphingolipid 
domains when compared to other areas of the cell membrane.  Using these protocols, 
many more proteins and lipid species can be examined to further our understanding of 
the cell membrane.   
The NanoSIMS data requires spatial statistics to determine the organization of 
membrane species.  The analysis of the lipid domains on a cell as well as the 
comparison to simulated data shows a non-random clustering of sphingolipids on the 
cell membrane.  This process can be applied to SIMS images or other imaging data 
such as fluorescence microscopy.    
Another SIMS technique, time-of-flight SIMS (TOF-SIMS) in conjunction with 
multivariate analysis (MVA) techniques allows complex, unlabeled samples to be 
investigated.  Even stem cells from a living organism can be classified using their 
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surface spectra and MVA.  Furthermore, the SIMS has location specificity and can 
image single cells.  This has implications in the tissue-engineering field, as many 
experimental conditions can be examined on the same substrate to determine what 
influences a cell’s differentiation, saving time and resources.   
Partial least squares regression (PLSR) is a MVA method that can provide 
quantitative information from TOF-SIMS data.1  Here a large portion of the mass 
spectrum (with the exception of known contamination) is used to investigate a 
homogeneous membrane containing cholesterol.  The PLSR model constructed from 
calibration data can be used to determine the cholesterol concentration in areas where 
the concentration is unknown.  The exchange of cholesterol was measured, as well as a 
sample with a gradient of cholesterol concentration.  This method could be used to 
investigate the partitioning of cholesterol in phase-separated samples.   
The capabilities of SIMS to investigate biological samples have begun to be 
realized.  The chemically specific, high imaging resolution of the NanoSIMS offers an 
amazing view of the structure of the cell membrane.  Further improvement in lateral 
resolution for TOF-SIMS would greatly enhance analysis capabilities and simplify 
sample preparation. 
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